學術研究成果/Publication
基本資料/Profiles
姓名/Name: 侯庭鏞 性別/Gender:
英文姓名/
English Name:
Ho, Tin-Yun 英文縮寫/
Abbreviation:
任職單位/
Affiliation:
1.中醫學院中醫學系學士班中醫基礎學科(教授) / School of Chinese Medicine- Basic Chinese Medicine (Professor)
Email: tyh@mail.cmu.edu.tw
研究專長/Fields of Specialty
1﹒ 中醫藥學 (Chinese Herbal Medicine)
2﹒ 新藥開發 (New Drug Development)
3﹒ 動物醫學 (Animal Medicine)
4﹒ 系統生物學 (Systems Biology)
5﹒ 微生物及免疫學 (Microbiology and Immunology)
 
期刊論文/Journal Paper
(作者群,論文題目,期刊名稱,出版年月,卷號(期別):頁次起迄)
SCI論文 侯庭鏞(Ho, Tin-Yun)、羅欣宜(Lo, Hsin-Yi)、劉宜臻(Liu, I-Chen)、林根安(Lin, Ken-An)、廖翊芳(YI-FANG,LIAO)、羅元鈞(Lo, Yuan-Chun)、項千芸*,The protective effect of quercetin on retinal inflammation in mice: the involvement of tumor necrosis factor/nuclear factor-κB signaling pathways,Food & Function,2020 Sep,11(9):8150-8160
SCI論文 吳菁山、李容妙(Rung-Miau Li)、羅欣宜(Lo, Hsin-Yi)、項千芸*、侯庭鏞*,Anti-hypertensive and angiotensin-converting enzyme inhibitory effects of Radix Astragali and its bioactive peptide AM-1,JOURNAL OF ETHNOPHARMACOLOGY,2020 May,254(23):112724
SCI論文 李容妙(Rung-Miau Li)、廖崇智(Chung-Chih Liao)、黃慧琪(Hui-Chi Huang)、林橙莉(Cheng-Li Lin)、羅欣宜(Lo, Hsin-Yi)、項千芸*、侯庭鏞*,Regulation effect and mechanism of Sheng-Hua-Tang on female reproductive system: From experimental transcriptomic analysis to clinical applications,JOURNAL OF ETHNOPHARMACOLOGY,2020 Mar,249():112431-112431
SCI論文 宋瑛琪(Ying-Chyi Song)、黃慧琪(Hui-Chi Huang)、張穎宜(Yin-Yi Chang)、李蕙汝(Hui-Ju Lee)、劉傳騰、羅欣宜(Lo, Hsin-Yi)、侯庭鏞、林武周(Wu-Chou Lin)、顏宏融(Hung-Rong Yen)*,A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses,Frontiers in Immunology,2020 Feb,11():62
SCI論文 宋瑛琪(Ying-Chyi Song)、洪國?(Kuo-Feng Hung)、梁凱莉(Kai-Li Liang)、(Jen-Huai Chiang)、黃慧琪(Hui-Chi Huang)、李蕙汝(Li, Hui-Ju)、吳美瑤(Mei-Yao Wu)、游勝傑(Sheng-Jie Yu)、羅欣宜(Lo, Hsin-Yi)、侯庭鏞、顏宏融(Hung-Rong Yen)*,Adjunctive Chinese herbal medicine therapy for nasopharyngeal carcinoma: Clinical evidence and experimental validation,HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK,2019 Sep,41(9):2860-2872
SCI論文 羅欣宜(Lo, Hsin-Yi)、李佳橙(Li, Chia-Cheug)、鄭慧滿(Hui-Man Cheng)、劉宜臻(Liu, I-Chen)、侯庭鏞*、項千芸*,Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice,FOOD AND CHEMICAL TOXICOLOGY,2019 Jul,129():365-375
SCI論文 李佳橙(Li, Chia-Cheug)、李育臣(Yu-Chen Lee)、羅欣宜(Lo, Hsin-Yi)、黃郁雯(Huang, Yu-Wen)、項千芸*、侯庭鏞*,Antihypertensive effects of corn silk extract and its novel bioactive constituent in spontaneously hypertensive rats: the involvement of angiotensin-converting enzyme inhibition,MOLECULES,2019 May,24(10):1886
SCI論文 (Wen-Yi Kao)、項千芸、(Shih-Ching Ho)、侯庭鏞*、(Kung-Ta Lee)*,Chemical Profiles of Incense Smoke Ingredients from Agarwood by Headspace Gas Chromatography-Tandem Mass Spectrometry,MOLECULES,2018 Nov,23(11):2969
SCI論文 李容妙(Rung-Miau Li)、李育臣(Lee, Yu-Chen)、李佳橙(Li, Chia-Cheug)、羅欣宜(Lo, Hsin-Yi)、陳鋒源(Feng-Yuan Chen)、陳怡秀(Yi-Siou Chen)、項千芸(Hsiang, Chien-Yun)*、侯庭鏞(Ho, Tin-Yun)*,Vanillin-Ameliorated Development of Azoxymethane/Dextran Sodium Sulfate-Induced Murine Colorectal Cancer: The Involvement of Proteasome/Nuclear Factor-κB/Mitogen-Activated Protein Kinase Pathways,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2018 Jun,66(22):5563-5573
SCI論文 (CHUNG-LIN TSAI)、(YING-MING CHIU)、侯庭鏞(Ho, Tin-Yun)、(CHIN-TUNG HSIEH)、(DONG-CHEN SHIEH)、(YI-JU LEE)、蔡嘉哲(Tsay, Gregory J)、吳怡瑩(Wu, Yi-Ying)*,Gallic Acid Induces Apoptosis in Human Gastric Adenocarcinoma Cells,ANTICANCER RESEARCH,2018 Apr,38(4):2057-2067
SCI論文 Huey-En Tzen、蔡俊灝(Tsai, Chun-Hao)、侯庭鏞(Ho, Tin-Yun)、(Chin-Tung Hsieh)、周聖杰(Chou, Shen-Chieh)、(Yi-Ju Lee)、蔡嘉哲(Tsay, Gregory J)、黃柏豪(Huang, Po-Hao)、吳怡瑩(Wu, Yi-Ying)*,Radix Paeoniae Rubra stimulates osteoclast differentiation by activation of the NF-κB and mitogen-activated protein kinase pathways,BMC Complementary and Alternative Medicine,2018 Apr,18(132):
SCI論文 程錦宜(Cheng, Chin-Yi)、侯庭鏞(Ho, Tin-Yun)、項千芸(Hsiang, Chien-Yun)、唐娜櫻(Tang, Nou-Ying)、謝慶良(Hsieh, Ching-Liang)、高尚德(Kao, Shung-Te)、李育臣(Lee, Yu-Chen)*,Angelica sinensis Exerts Angiogenic and Anti-apoptotic Effects Against Cerebral Ischemia–Reperfusion Injury by Activating p38MAPK/HIF-1α/VEGF-A Signaling in Rats,AMERICAN JOURNAL OF CHINESE MEDICINE,2017 Nov,45(8):1683-1708
SCI論文 鄭慧滿(Cheng, Hui-Man)、陳鋒源(Feng-Yuan Chen)、李佳橙(Li, Chia-Cheug)、羅欣宜(Lo, Hsin-Yi)、廖翊芳(YI-FANG,LIAO)、侯庭鏞(Ho, Tin-Yun)*、項千芸(Hsiang, Chien-Yun)*,Oral Administration of Vanillin Improves Imiquimod-Induced Psoriatic Skin Inflammation in Mice,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2017 Nov,65(47):10233-10242
SCI論文 羅欣宜(Hsin-Yi Lo)、李佳橙(Chia-Cheng Li)、陳鋒源(Feng-Yuan Chen)、陳兆群(Jaw-Chyun Chen)、項千芸(Hsiang, Chien-Yun)*、侯庭鏞(Ho, Tin-Yun)*,Gastro-Resistant Insulin Receptor-Binding Peptide from Momordica charantia Improved the Glucose Tolerance in Streptozotocin-Induced Diabetic Mice via Insulin Receptor Signaling Pathway,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2017 Oct,65(42):9266-9274
SCI論文 吳菁山、羅欣宜(Lo, Hsin-Yi)、李佳橙(Li, Chia-Cheug)、陳鋒源(Feng-Yuan Chen)、項千芸(Hsiang, Chien-Yun)*、侯庭鏞(Ho, Tin-Yun)*,Comprehensive evaluation of gene expression signatures in response to electroacupuncture stimulation at Zusanli (ST36) acupoint by transcriptomic analysis,BMC Complementary and Alternative Medicine,2017 Aug,17(1):406-406
SCI論文 周順頂(Shun-Ting Chou)、項千芸(Chien-Yun Hsiang)、羅欣宜(Hsin-Yi Lo)、黃惠棻(Hui-Fen Huang)、賴銘倧(Ming-Tsung Lai)、謝慶良(Ching-Liang Hsieh)、江素瑛(Su-yin Chiang)*、侯庭鏞(Tin-Yun Ho)*,Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice,BMC Complementary and Alternative Medicine,2017 Feb,17(1):121
SCI論文 唐娜櫻(Nou-Ying Tang)、林以文(Lin Yi-Wen)、侯庭鏞(Tin-Yun Ho)、程錦宜(Chin-Yi Cheng)、(Chao-Hsiang Chen)、謝慶良(Ching-Liang Hsieh)*,Long-Term Intake of Uncaria rhynchophylla Reduces S100B and RAGE Protein Levels in Kainic Acid-Induced Epileptic Seizures Rats,Evidence-based Complementary and Alternative Medicine,2017 Feb,2017(9732854):
SCI論文 侯庭鏞(Tin-Yun Ho)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、陳鋒源(Feng-Yuan Chen)、項千芸(Chien-Yun Hsiang)*,Corn silk extract and its bioactive peptide ameliorated lipopolysaccharide-induced inflammation in mice via nuclear factor-κB signaling pathway,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2017 Feb,65(4):759-768
SCI論文 羅欣宜(Hsin-Yi Lo)、李采娟(Tsai-Chung Li)、楊哲彥(Tse-Yen Yang)、李佳橙(Chia-Cheng Li)、(Jen-Huai Chiang)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*,Hypoglycemic effects of Trichosanthes kirilowii and its protein constituent in diabetic mice: the involvement of insulin receptor pathway,BMC Complementary and Alternative Medicine,2017 Jan,17(1):53
SCI論文 周順頂(Shun-Ting Chou)、羅欣宜(Hsin-Yi Lo)、李佳橙(Chia-Cheng Li)、鄭律溱(Lu-Chen Cheng)、周珮琪(Chou PeiChi)、李育臣(Yu-Chen Lee)、侯庭鏞(Tin-Yun Ho)*、項千芸(Chien-Yun Hsiang)*,Exploring the effect and mechanism of Hibiscus sabdariffa on urinary tract infection and experimental renal inflammation,JOURNAL OF ETHNOPHARMACOLOGY,2016 Dec,194():617-625
SCI論文 廖文彥(Liao, wen-yen)、蔡東湖(Tung-Hu Tsai)、侯庭鏞(Tin-Yun Ho)、林以文(Lin Yi-Wen)、程錦宜(Chin-Yi Cheng)、謝慶良(Ching-Liang Hsieh)*,Neuroprotective Effect of Paeonol Mediates Anti-Inflammation via Suppressing Toll-Like Receptor 2 and Toll-Like Receptor 4 Signaling Pathways in Cerebral Ischemia-Reperfusion Injured Rats,Evidence-based Complementary and Alternative Medicine,2016 Dec,2016():
SCI論文 羅欣宜(Hsin-Yi Lo)、李佳橙(Chia-Cheng Li)、侯庭鏞(Tin-Yun Ho)*、項千芸(Chien-Yun Hsiang)*,Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein,FOOD CHEMISTRY,2016 Aug,204():298-305
SCI論文 (Chung-Ta Chang)、項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)、(Ching-Zong Wu)、(Hsiang-Hsi Hong)、(Yi-Fang Huang)*,Comprehensive assessment of host responses to 5-fluorouracil-induced oral mucositis through transcriptomic analysis,PLoS One,2015 Aug,10(8):e0135102-e0135102
SCI論文 項千芸(Chien-Yun Hsiang)、林麗娟(Li-Jen Lin)、高尚德(Shung-Te Kao)、羅欣宜(Hsin-Yi Lo)、周順頂(Shun-Ting Chou)、侯庭鏞(Tin-Yun Ho)*,Glycyrrhizin, silymarin, and ursodeoxycholic acid regulate a common hepatoprotective pathway in HepG2 cells,PHYTOMEDICINE,2015 Jul,22(7-8):768-777
SCI論文 項千芸(Chien-Yun Hsiang)、鄭慧滿(Hui-Man Cheng)、羅欣宜(Hsin-Yi Lo)、李佳橙(Chia-Cheng Li)、周珮琪(Chou PeiChi)、李育臣(Yu-Chen Lee)、侯庭鏞(Tin-Yun Ho)*,Ginger and zingerone ameliorate lipopolysaccharide-induced acute systemic inflammation in mice, assessed by nuclear factor-κB bioluminescent imaging,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2015 Jul,63(26):6051-6058
SCI論文 曾崇育(Chung-Yuh Tzeng)、李育臣(Yu-Chen Lee)、侯庭鏞(Tin-Yun Ho)、(Ying-I Chen)、(Tai-Hao Hsu)、林昭庚(Jaung-Geng Lin)、(Kuan-Rong Lee)*、張世良(Shih-Liang Chang)*,Intracellular signalling pathways associated with the glucose-lowering effect of ST36 electroacupuncture in streptozotocin-induced diabetic rats,Acupuncture in Medicine,2015 May,():
SCI論文 羅欣宜(Hsin-Yi Lo)、項千芸(Chien-Yun Hsiang)、李采娟(Tsai-Chung Li)、李佳橙(Chia-Cheng Li)、黃慧琪(Hui-Chi Huang)、陳兆群(Jaw-Chung Chen)、侯庭鏞(Tin-Yun Ho)*,A novel glycated hemoglobin A1c-lowering traditional Chinese medicinal formula, identified by translational medicine study,PLoS One,2014 Aug,9(8):e104650-e104650
SCI論文 羅欣宜(Hsin-Yi Lo)、侯庭鏞(Tin-Yun Ho)、李佳橙(Chia-Cheng Li)、陳兆群(Jaw-Chyun Chen)、劉昭君(Jau Jin Liu)、項千芸(Chien-Yun Hsiang)*,A novel insulin receptor-binding protein from Momordica charantia enhances glucose uptake and glucose clearance in vitro and in vivo through triggering insulin receptor signaling pathway,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2014 Aug,62(36):8952-8961
SCI論文 侯庭鏞(Tin-Yun Ho)、羅欣宜(Hsin-Yi Lo)、趙德澂(De-Cheng Chao)、李佳橙(Chia-Cheng Li)、劉昭君(Jau Jin Liu)、林靜茹(Chingju Lin)、項千芸(Chien-Yun Hsiang)*,Electroacupuncture improves trinitrobenzene sulfonic acid-induced colitis, evaluated by transcriptomic study,Evidence-based Complementary and Alternative Medicine,2014 Jun,2014(6):942196-942196
SCI論文 侯庭鏞(Tin-Yun Ho)、唐娜櫻(Nou-Ying Tang)、項千芸(Chien-Yun Hsiang)、謝慶良(Ching-Liang Hsieh)*,Uncaria rhynchophylla and rhynchophylline improved kainic acid-induced epileptic seizures via IL-1β and brain-derived neurotrophic factor,PHYTOMEDICINE,2014 May,21(5):893-900
SCI論文 陳兆群(J.C. Chen)、項千芸(Chien-Yun Hsiang)、林永昌(Y.C. Lin)、侯庭鏞(Tin-Yun Ho)*,Deer antler extract improves fatigue effect through altering the expression of genes related to muscle strength in skeletal muscle of mice,Evidence-based Complementary and Alternative Medicine,2014 Feb,2014(2):540580-540580
SCI論文 (Hung-Chi Chang)、(Jaw-Chyun Chen)、(Jiun-Long Yang)、(Hsin-Sheng Tsay)、項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)*,The suppressive activities of six sources of medicinal ferns known as “Gusuibu” on heat-labile enterotoxin-induced diarrhea,MOLECULES,2014 Feb,19(2):2114-2120
Other論文 侯庭鏞(Tin-Yun Ho)、羅欣宜(Hsin-Yi Lo)、李佳橙(Chia-Cheng Li)、陳兆群(Jaw-Chyun Chen)、項千芸(Chien-Yun Hsiang)*,In vitro and in vivo bioluminescent imaging to evaluate anti-Escherichia coli activity of Galla Chinensis,BioMedicine,2013 Dec,3(4):160-166
SCI論文 羅欣宜(Hsin-Yi Lo)、侯庭鏞(Tin-Yun Ho)、林靜茹(Chingju Lin)、李佳橙(Chia-Cheng Li)、項千芸(Chien-Yun Hsiang)*,Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2013 Mar,61(10):2461-2468
SCI論文 項千芸(Chien-Yun Hsiang)、許游章(You-Cheng Hseu)、張益銍(Yi-Chih, Chang)、(K.J.Sl Kumar)、侯庭鏞(Tin-Yun Ho)*、楊新玲(Yang Hsin-ling)*,Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-B transgenic mice as evaluated by in vivo bioluminescence imaging,FOOD CHEMISTRY,2013 Jan,136(2):426-434
SCI論文 項千芸(Chien-Yun Hsiang)、羅欣宜(Hsin-Yi Lo)、黃慧琪(Hui-Chi Huang)、李佳橙(Chia-Cheng Li)、吳世祿(Shih-Lu Wu)、侯庭鏞(Tin-Yun Ho)*,Ginger extract and zingerone ameliorated trinitrobenzene sulfonic acid-induced colitis in mice via modulation of nuclear factor-κB activity and interleukin-1β signaling pathway,FOOD CHEMISTRY,2013 Jan,136(1):170-177
SCI論文 李佳橙(Chia-Cheng Li)、項千芸(Chien-Yun Hsiang)、羅欣宜(Hsin-Yi Lo)、白馥慈(Fu-Tzu Pai)、吳世祿(Shih-Lu Wu)、侯庭鏞(Tin-Yun Ho)*,Genipin inhibits lipopolysaccharide-induced acute systemic inflammation in mice as evidenced by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis,FOOD AND CHEMICAL TOXICOLOGY,2012 Sep,50(9):2978-2986
SCI論文 劉玉晴(Yu-Ching Liu)、何恒堅(Heng-Chien Ho)、李妙蓉(Miau-Rong Lee)、賴光啟(Kuang-Chi Lai)、葉仲敏(Chung-Min Yeh)、林月明(Yueh-Min Lin)、侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang)*、鍾景光(Jing-Gung Chung)*,Early induction of cytokines/cytokine receptors and Cox2, and activation of NF-kappaB in 4-nitroquinoline 1-oxide-induced murine oral cancer model,TOXICOLOGY AND APPLIED PHARMACOLOGY,2012 Jul,262(2):107-116
SCI論文 李德茂(Te-Mao Li)、黃心治(Huang Hsin-Chih)、蘇振銘(Su Chen-Ming)、侯庭鏞(Tin-Yun Ho)、吳啟銘(Wu Chi-Ming)、陳汶吉(Chen, Wen-Chi)、馮逸卿(Yi-Chin Fong)、湯智昕(Tang Chih-Hsin)*,Cistanche deserticola extract increases bone formation in osteoblasts.,JOURNAL OF PHARMACY AND PHARMACOLOGY,2012 Jun,64(6):897-907
SCI論文 李佳橙(Chia-Cheng Li)、項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、侯庭鏞(Tin-Yun Ho)*,Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis,FOOD AND CHEMICAL TOXICOLOGY,2012 May,50(5):1568-1575
Other論文 羅欣宜(Hsin-Yi Lo)、李佳橙(Chia-Cheng Li)、黃慧琪(Hui-Chi Huang)、林麗娟(Li-Jen Lin)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*,Application of transcriptomics in Chinese herbal medicine studies,Journal of Traditional and Complementary Medicine,2012 Apr,2(2):105-114
SCI論文 高嘉鴻(Chia-Hung Kao)、項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)*,Assessment of chitosan-affected metabolic response by peroxisome proliferator-activated receptor bioluminescent imaging-guided transcriptomic analysis,PLoS One,2012 Apr,7(4):e34969-e34969
Other論文 李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*,DNA microarray analysis as a tool to investigate the therapeutic mechanisms and drug development of Chinese medicinal herbs,BioMedicine,2012 Mar,2(1):10-16
SCI論文 張仲達(Chung-Ta Chang)、侯庭鏞(Tin-Yun Ho)、林赫(Ho Lin)、梁基安(Ji-An Liang)、黃慧琪(Hui-Chi Huang)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、吳世祿(Shih-Lu Wu)、黃意芳(Yi-Fang Huang)、項千芸(Chien-Yun Hsiang)*,5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging,PLoS One,2012 Mar,7(3):e31808-e31808
SCI論文 (Wei-Hsin Chen)、謝慶良(Ching-Liang Hsieh)、(Chun-Ping Huang)、(Tzu-Jou Lin)、(Jason T.C. Tzen)、侯庭鏞(Tin-Yun Ho)*、林以文(Lin Yi-Wen)*,Acid-sensing ion channel 3 mediates peripheral anti-hyperalgesia effects of acupuncture in mice inflammatory pain,JOURNAL OF BIOMEDICAL SCIENCE,2011 Dec,18():
SCI論文 張仲達(Chung-Ta Chang)、林赫(Ho Lin)、侯庭鏞(Tin-Yun Ho)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、吳世祿(Shih-Lu Wu)、黃意芳(Yi-Fang Huang)、梁基安(Ji-An Liang)*、項千芸(Chien-Yun Hsiang)*,Comprehensive assessment of host responses to ionizing radiation by nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis,PLoS One,2011 Aug,6(8):e23682-e23682
SCI論文 趙德澂(De-Cheng Chao)、林麗娟(Li-Jen Lin)、項千芸(Chien-Yun Hsiang)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、梁基安(Ji-An Liang)、高尚德(Shung-Te Kao)、吳世祿(Shih-Lu Wu)、侯庭鏞(Tin-Yun Ho)*,Evodiamine Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Activator Protein 1 Transactivation and Cell Transformation in Human Hepatocytes,PHYTOTHERAPY RESEARCH,2011 Jul,25(7):1018-1023
SCI論文 趙德澂(De-Cheng Chao)、林麗娟(Li-Jen Lin)、高尚德(Shung-Te Kao)、黃慧琪(Hui-Chi Huang)、張誌祥(Chih-Shiang Chang)、梁基安(Ji-An Liang)、吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*,Inhibitory effects of Zuo-Jin-Wan and its alkaloidal ingredients on activator protein 1, nuclear factor-κB, and cellular transformation in HepG2 cells,FITOTERAPIA,2011 Jun,82(4):696-703
SCI論文 向士偉(Shih-Wei Hsiang)、蔡金川(Chin-Chuan Tsai)、侯庭鏞(Tin-Yun Ho)*、姚俊旭(Chun-Hsu Yao)*、陳悅生(Yueh-Sheng Chen)*,Novel use of biodegradable casein conduits for guided peripheral nerve regeneration,Journal of the Royal Society Interface,2011 Jun,():
SCI論文 蘇珊玉(Shan-Yu Su)、程錦宜、蔡東湖(Tung-Hu Tsai)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*、謝慶良(Ching-Liang Hsieh)*,Paeonol attenuates H2O2-induced NF-κB-associated amyloid precursor protein expression,AMERICAN JOURNAL OF CHINESE MEDICINE,2010 Dec,38(6):1171-1192
SCI論文 鄭慧滿(Hui-Man Cheng)、李佳橙(Chia-Cheng Li)、陳語謙(Calvin Yu-Chian Chen)、羅欣宜(Hsin-Yi Lo)、鄭文裕(Wen-Yu Cheng)、李昌諴(Chang-Hsien Lee)、楊仕哲(Su-Tso Yang or YANG Shi-zhe)、吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*,Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation,JOURNAL OF ETHNOPHARMACOLOGY,2010 Nov,132(2):429-437
SCI論文 李佳橙(Chia-Cheng Li)、侯庭鏞(Tin-Yun Ho)、高嘉鴻(Chia-Hung Kao)、吳世祿(Shih-Lu Wu)、梁基安(Ji-An Liang)、項千芸(Chien-Yun Hsiang)*,Conserved charged amino acid residues in the extracellular region of sodium/iodide symporter are critical for iodide transport activity,JOURNAL OF BIOMEDICAL SCIENCE,2010 Nov,17(1):89-98
SCI論文 程錦宜(Chin-Yi Cheng)、蘇珊玉(Shan-Yu Su)、唐娜櫻(Nou-Ying Tang)、侯庭鏞(Tin-Yun Ho)、羅婉瑜(Wan-Yu Lo)、謝慶良(Ching-Liang Hsieh)*,Ferulic acid inhibits nitric oxide-induced apoptosis by enhancing GABAB1 receptor expression in transient focal cerebral ischemia in rats,ACTA PHARMACOLOGICA SINICA,2010 Aug,31(8):889-899
SCI論文 陳雅吟(Chen Ya-Yin)、鍾景光(Jing-Gung Chung)、吳琇卿(Wu,Hsiu-Ching)、包大靝(Da-Tian Bau)、吳焜裕、高尚德(Shung-Te Kao)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*、江素瑛(Su-yin Chiang)*,Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells,ONCOLOGY REPORTS,2010 Jun,24():141-153
SCI論文 陳雅吟(Chen Ya-Yin)、江素瑛(Su-yin Chiang)、吳琇卿(Wu,Hsiu-Ching)、高尚德(Shung-Te Kao)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*、林昭庚(Jaung-Geng Lin)*,Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells,ACTA PHARMACOLOGICA SINICA,2010 Feb,31(2):227-236
SCI論文 章如瑛(Ju-Ying Chang)、侯庭鏞(Tin-Yun Ho)、李漢忠(Han-Chung Lee)、賴彥良(Yen-Liang Lai)、呂明進(Ming-Chin Lu)*、姚俊旭(Chun-Hsu Yao)*、陳悅生(Yueh-Sheng Chen)*,Highly Permeable Genipin-Cross-linked Gelatin Conduits Enhance Peripheral Nerve Regeneration,ARTIFICIAL ORGANS,2009 Dec,33(12):1075-1085
EI論文 黃泓縉(Hung-Jin Huang)、蔡輔仁(Fuu-Jen Tsai)、鍾景光(Jing-Gung Chung)、蔡長海(Chang-Hai Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、(Yea-Huey Chang)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、陳語謙(Calvin Yu-Chian Chen)*,Drug Design for XRCC4 in Silico,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):192-195
EI論文 陳建宇(Chien-Yu Chen)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、黃泓縉(Hung-Jin Huang)、(Yea-Huey Chang)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、陳語謙(Calvin Yu-Chian Chen)*,Is That Possible to Design the Versatile Inhibitors for H1N1, H5N1, H5N2, and H5N7 ?,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):5-8
EI論文 陳建宇(Chien-Yu Chen)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、黃泓縉(Hung-Jin Huang)、(Yea-Huey Chang)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、陳語謙(Calvin Yu-Chian Chen)*,Drug Design for the Influenza A Virus Subtype H1N1,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):268-270
EI論文 黃泓縉(Hung-Jin Huang)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、陳建宇(Chien-Yu Chen)、(Yea-Huey Chang)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、陳語謙(Calvin Yu-Chian Chen)*,Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):837-841
EI論文 陳建宇(Chien-Yu Chen)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、黃泓縉(Hung-Jin Huang)、(Yea-Huey Chang)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、陳語謙(Calvin Yu-Chian Chen)*,Drug Design for KU86 in DNA Break Repair System,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):1-4
EI論文 陳建宇(Chien-Yu Chen)、蔡輔仁(Fuu-Jen Tsai)、鍾景光(Jing-Gung Chung)、蔡長海(Chang-Hai Tsai)、徐媛曼(Yuan-Man Hsu)、黃泓縉(Hung-Jin Huang)、侯庭鏞(Tin-Yun Ho)、(Yea-Huey Chang)、(Bau Da Tien)、陳語謙(Calvin Yu-Chian Chen)*,A Novel Strategy for Designing Dual-target Inhibitors of KU86 and XRCC4,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):1636-1639
EI論文 (Yea-Huey Chang)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、陳建宇(Chien-Yu Chen)、黃泓縉(Hung-Jin Huang)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、陳語謙(Calvin Yu-Chian Chen)*,Reducing without Side Effects? A Novel Strategy for Designing the PPAR Agonists,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):66-69
EI論文 黃泓縉(Hung-Jin Huang)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、陳建宇(Chien-Yu Chen)、(Yea-Huey Chang)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、陳語謙(Calvin Yu-Chian Chen)*,What is the Key Point for Designing HER2 Inhibitors ?,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):1452-1456
EI論文 陳建宇(Chien-Yu Chen)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、黃泓縉(Hung-Jin Huang)、(Yea-Huey Chang)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、陳語謙(Calvin Yu-Chian Chen)*,Drug Design for AMP-Activated Protein Kinase Agonists in Silico,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):188-191
EI論文 陳建宇(Chien-Yu Chen)、(Bau Da Tien)、蔡銘修(Ming-Hsui Tsai)、徐媛曼(Yuan-Man Hsu)、侯庭鏞(Tin-Yun Ho)、黃泓縉(Hung-Jin Huang)、(Yea-Huey Chang)、蔡輔仁(Fuu-Jen Tsai)、蔡長海(Chang-Hai Tsai)、陳語謙(Calvin Yu-Chian Chen)*,Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction ?,BioMedical Engineering and Informatics: New Development and the Future - Proceedings of the 1st International Conference on BioMedical Engineering and Informatics, BMEI 2008,2009 Oct,none(none):196-200
SCI論文 吳世祿(Shih-Lu Wu)、陳兆群(Jaw-Chyun Chen)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、侯庭鏞(Tin-Yun Ho)*、項千芸(Chien-Yun Hsiang)*,Vanillin improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice,JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2009 Aug,330(2):370-376
SCI論文 鄭文裕(Cheng, W.Y.)、連金城(Lien Jin Cherng)、項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、陳兆群(Jaw-Chyun Chen)、江素瑛(Su-yin Chiang)、梁基安(Ji-An Liang)、侯庭鏞(Tin-Yun Ho)*,Comprehensive evaluation of a novel nuclear factor-κB inhibitor, quinoclamine, by transcriptomic analysis,BRITISH JOURNAL OF PHARMACOLOGY,2009 Jul,157(5):746-756
SCI論文 項千芸(Chien-Yun Hsiang)、陳悅生(Yueh-Sheng Chen)、侯庭鏞(Tin-Yun Ho)*,Nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis for the assessment of hoist-biomaterial interaction in vivo,BIOMATERIALS,2009 Jun,30(17):3042-3049
SCI論文 蘇珊玉(Shan-Yu Su)、謝慶良(Ching-Liang Hsieh)、吳世祿(Shih-Lu Wu)、鄭文裕(Wen-Yu Cheng)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、侯庭鏞(Tin-Yun Ho)*、項千芸(Chien-Yun Hsiang)*,Transcriptomic analysis of EGb 761-regulated neuroactive receptor pathway in vivo,JOURNAL OF ETHNOPHARMACOLOGY,2009 May,123(1):68-73
SCI論文 (Chang, T.J.)、(Chang, Y.J.)、侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang)、(Yu, C.Y.)、(Lee, T.W.)、(Lin, W.J.)、(Chang, C.H.)*,Noninvasive bioluminescent and microPET imaging for the regulation of NF-kB in human hepatoma-bearing mice,ANTICANCER RESEARCH,2009 Apr,29(4):987-994
SCI論文 謝慶良(Ching-Liang Hsieh)、侯庭鏞(Tin-Yun Ho)、蘇珊玉(Shan-Yu Su)、羅婉瑜(Wan-Yu Lo)、劉崇祥(Chung-Hsiang Liu)、唐娜櫻(Nou-Ying Tang)*,Uncaria rhynchophylla and rhynchophylline inhibit c-Jun N-terminal kinase phosphorylation and nuclear factor-κB activity in kainic acid-treated rats.,AMERICAN JOURNAL OF CHINESE MEDICINE,2009 Apr,37(2):351-360
SCI論文 吳世祿(Shih-Lu Wu)、李佳橙(Chia-Cheng Li)、侯庭鏞(Tin-Yun Ho)*、項千芸(Chien-Yun Hsiang)*,Mutagenesis identifies the critical regions and amino acid residues of suid herpesvirus 1 DNA-binding protein required for DNA binding and strand invasion,VIRUS RESEARCH,2009 Mar,140(1-2):147-154
SCI論文 梁基安(Ji-An Liang)、吳世祿(Shih-Lu Wu)、羅欣宜(Hsin-Yi Lo)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*,Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-κB signaling pathway in human hepatocellular carcinoma cells,MOLECULAR PHARMACOLOGY,2009 Jan,75(1):151-157
SCI論文 吳世祿(Shih-Lu Wu)、李佳橙(Chia-Cheng Li)、陳兆群(Jaw-Chyun Chen)、陳奕瑾(Yi-Jin Chen)、林靖婷(Ching-Ting Lin)、侯庭鏞(Tin-Yun Ho)*、項千芸(Chien-Yun Hsiang)*,Mutagenesis identifies the critical amino acid residues of human endonuclease G involved in catalysis, magnesium coordination, and substrate specificity,JOURNAL OF BIOMEDICAL SCIENCE,2009 Jan,16(1):6-6
SCI論文 陳兆群(Jaw-Chyun Chen)、侯庭鏞(Tin-Yun Ho)、張永勳(Yuan Shiun Chang)、吳世祿(Shih-Lu Wu)、李佳橙(Chia-Cheng Li)、項千芸(Chien-Yun Hsiang)*,Identification of E. coli enterotoxin inhibitors from traditional medical herbs by in silico, in vitro, and in vivo analyses,JOURNAL OF ETHNOPHARMACOLOGY,2009 Jan,121(3):372-378
SCI論文 程錦宜(Chin-Yi Cheng)、侯庭鏞(Tin-Yun Ho)、李宜堅(E.-Jian Lee)、蘇珊玉(Shan-Yu Su)、唐娜櫻(Nou-Ying Tang)、謝慶良(Ching-Liang Hsieh)*,Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats.,AMERICAN JOURNAL OF CHINESE MEDICINE,2008 Dec,36(6):1105-1119
SCI論文 李昌諴(Chang-Hsien Lee)、吳世祿(Shih-Lu Wu)、陳兆群(Jaw-Chyun Chen)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、鄭文裕(Wen-Yu Cheng)、林昭庚(Jaung-Geng Lin)、張永賢(Yung-Hsien Chang)、項千芸(Chien-Yun Hsiang)*、侯庭鏞(Tin-Yun Ho)*,Eriobotrya japonica leaf and its triterpenes inhibited lipopolysaccharide-induced cytokines and inducible enzyme production via the nuclear factor-κB signaling pathway in lung epithelial cells,AMERICAN JOURNAL OF CHINESE MEDICINE,2008 Nov,36(6):1185-1198
SCI論文 吳世祿(Shih-Lu Wu)、侯庭鏞(Tin-Yun Ho)、梁基安(Ji-An Liang)、項千芸(Chien-Yun Hsiang)*,Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter,JOURNAL OF ENDOCRINOLOGY,2008 Nov,199(2):213-219
Other論文 周立琛(Li-Chen Chou)、吳啟瑞(Chi-Rei Wu)、李秉文(Ping-Wen Li)、王繼平(Jih-Pyang Wang)、黃麗嬌(Li-Jiau Huang)、郭盛助(Sheng-Chu Kuo)、侯庭鏞(Tin-Yun Ho)*、連金城(Lien Jin Cherng)*,Synthesis of 2,3-Disubstituted 1,4-Naphthoquinones as Anti-inflammatory and Antiallergic Agents,Taiwan Pharmaceutical Journal,2008 Oct,60(1):39-49
SCI論文 項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)*,Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures,BRITISH JOURNAL OF PHARMACOLOGY,2008 Sep,155(2):227-235
MT論文 張清貿(Ching-Mao Chang)、侯庭鏞(Tin-Yun Ho)、朱學亭(Hsueh-Ting Chu)、李佳橙(Chia-Cheng Lee)、張永賢(Yung-Hsien Chang)*,A mathematical method to differentiate the effects of “Aconitum carmichaeli Debx” in different prescriptions,Mid-Taiwan Journal of Medicine,2008 Sep,13(3):152-157
SCI論文 鄭文裕(Wen-Yu Cheng)、吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang)、李佳橙(Chia-Cheng Li)、賴東淵(Tung-Yuan Lai)、羅欣宜(Hsin-Yi Lo)、沈偉舜(Wei-Shuen Shen)、李昌諴(Chang-Hsien Lee)、陳兆群(Jaw-Chyun Chen)、吳琇卿(Wu,Hsiu-Ching)、侯庭鏞(Tin-Yun Ho)*,Relationship between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells.,AMERICAN JOURNAL OF CHINESE MEDICINE,2008 Jul,36(4):783-797
SCI論文 鄭慧滿(Hui-Man Cheng)、項千芸(Chien-Yun Hsiang)、陳光偉(Guang-Wei Chen)、吳世祿(Shih-Lu Wu)、陳兆群(Jaw-Chyun Chen)、黃志揚、包大靝(Da-Tian Bau)*、侯庭鏞(Tin-Yun Ho)*,Inhibition of lipopolysaccharide-induced interleukin-1β and tumor necrosis factor-α production by menthone through nuclear factor-κB signaling pathway in HaCat cells,CHINESE JOURNAL OF PHYSIOLOGY,2008 Jun,51(3):160-166
MT論文 謝慶良(Ching-Liang Hsieh)、侯庭鏞(Tin-Yun Ho)、蘇珊玉(Shan-Yu Su)、程錦宜、徐維聰(Wei-Tsung Hsu)、謝慶竇、蒲曉韻、唐娜櫻(Nou-Ying Tang)*,Gui-Zhi-Fu-Ling-Wan Reduces CerebralInfarction Area via the Anti-inflammatory Effects in Ischemia-reperfusion Injured Rats,Mid-Taiwan Journal of Medicine,2008 Mar,13(1):1-11
SCI論文 梁智凱、侯庭鏞(Tin-Yun Ho)、李采娟(Tsai-Chung Li)、許紋銘(Wen-Ming Hsu)、李德茂(Te-Mao Li)、李育臣(Yu-Chen Lee)、何偉真(Wai-Jane Ho)、鄭瑞棠(Juei-Tang Cheng)、曾崇育(Chung-Yuh Tzeng)、劉怡婷(I-Ting Liu)、張世良(Chang, Shih Liang)*,A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial,COMPLEMENTARY THERAPIES IN MEDICINE,2008 ,16(6):305-310
SCI論文 鄭文裕(Wen-Yu Cheng)、項千芸(Chien-Yun Hsiang)、包大靝(Da-Tian Bau)、陳兆群(Jaw-Chyun Chen)、沈偉舜(Wei-Shuen Shen)、李佳橙(Chia-Cheng Li)、羅欣宜(Hsin-Yi Lo)、吳世祿(Shih-Lu Wu)、江素瑛(Su-yin Chiang)、侯庭鏞(Tin-Yun Ho)*,Microarray analysis of vanillin-regulated gene expression profile in human hepatocarcinoma cells,PHARMACOLOGICAL RESEARCH,2007 Dec,56(6):474-482
SCI論文 侯庭鏞(Tin-Yun Ho)、陳悅生(Yueh-Sheng Chen)、項千芸(Chien-Yun Hsiang)*,Noninvasive nuclear factor-κB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice,BIOMATERIALS,2007 Oct,28(30):4370-4377
SCI論文 陳兆群(Jaw-Chyun Chen)、黃麗嬌(Li-Jiau Huang)、吳世祿(Shih-Lu Wu)、郭盛助(Sheng-Chu Kuo)、侯庭鏞(Tin-Yun Ho)*、項千芸(Chien-Yun Hsiang)*,Ginger and its bioactive component inhibit enterotoxigenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,2007 Oct,55(21):8390-8397
SCI論文 李昌諴(C.H. Lee)、陳兆群(Jaw-Chyun Chen)、項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、吳琇卿(Wu,Hsiu-Chung)、侯庭鏞(Tin-Yun Ho)*,Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells,PHARMACOLOGICAL RESEARCH,2007 Sep,56(3):193-201
SCI論文 陳兆群(Jaw-Chyun Chen)、張永勳(Yuan Shiun Chang)、吳世祿(Shih-Lu Wu)、趙德澂(De-Cheng Chao)、張誌祥(Chih-Shiang Chang)、李佳橙(Chia-Cheng Li)、侯庭鏞(Tin-Yun Ho)*、項千芸(Chien-Yun Hsiang)*,Inhibition of Escherichia coli heat-labile enterotoxin-induced diarrhea by Chaenomeles speciosa,JOURNAL OF ETHNOPHARMACOLOGY,2007 Aug,113(2):233-239
SCI論文 項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、陳兆群(Jaw-Chyun Chen)、羅欣宜(Hsin-Yi Lo)、李佳橙(Chia-Cheng Li)、江素瑛(Su-yin Chiang)、吳琇卿(Wu,Hsiu-Chung)、侯庭鏞(Tin-Yun Ho)*,Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-κB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: association with the invasive potential,TOXICOLOGY LETTERS,2007 Jun,171(1-2):78-86
SCI論文 侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、陳兆群(Jaw-Chyun Chen)、李佳橙(Chia-Cheng Li)、項千芸(Chien-Yun Hsiang)*,Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction,ANTIVIRAL RESEARCH,2007 May,74(2):92-101
SCI論文 謝慶良(Ching-Liang Hsieh)、林昭庚、江素瑛(Su-yin Chiang)、蘇珊玉(Shan-Yu Su)、唐娜櫻、林宜信(I-Hsin Lin)、劉崇祥(Chung-Hsiang Liu)、項千芸(Chien-Yun Hsiang)、陳兆群(Jaw-Chyun Chen)、侯庭鏞(Tin-Yun Ho)*,Gastrodia elata modulated activator protein 1 via c-Jun N-terminal kinase signaling pathway in kainic acid-induced epilepsy in rats.,JOURNAL OF ETHNOPHARMACOLOGY,2007 Jan,109(2):241-247
SCI論文 侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、陳兆群(Jaw-Chyun Chen)、魏鷰驕(Yen-Chiao Wei)、鄭欣怡(Shin-Ei Cheng)、張永賢(Chang,Yung-Hsien)、劉旭然(Hsu-Jan Liu)、項千芸(Chien-Yun Hsiang)*,Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction,ANTIVIRAL RESEARCH,2006 Feb,2(69):70-76
SCI論文 陳兆群(Jaw-Chyun Chen)、侯庭鏞(Tin-Yun Ho)、張永勳(Yuan Shiun Chang)、吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang)*,Anti-diarrheal effect of Galla Chinensis on the Escherichia coli heat-labile enterotoxin and ganglioside interaction,JOURNAL OF ETHNOPHARMACOLOGY,2006 Feb,103(3):385-391
SCI論文 梁基安(Liang,Ji-An)、陳君萍(Chun-Ping Chen)、黃信哲、侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang)、丁慧枝(Hueisch-Jy Ding)、吳世祿(Shih-Lu Wu)*,A novel loss-of-function deletion in sodium/iodide symporter gene in follicular thyroid adenoma,CANCER LETTERS,2005 Dec,230(1):65-71
SCI論文 項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、鄭欣怡(Shin-Ei Cheng)、侯庭鏞(Tin-Yun Ho)*,Acetaldehyde-induced interleukin-1β and tumor necrosis factor-α production is inhibited by berberine through nuclear factor-κB signaling pathway in HepG2 cells,JOURNAL OF BIOMEDICAL SCIENCE,2005 Oct,12(5):791-801
SCI論文 林振文(Cheng-Wen Lin)*、蔡輔仁(Tsai,Fuu-Jen)、蔡長海、賴建成(Chien-Chen Lai)、萬磊(Lei Wan)、侯庭鏞(Tin-Yun Ho)、謝長奇(Hsieh, Chang-Chi)、李珮端,Anti-SARS coronavirus 3C-like protease effects of Isatis indifotica root and plant-derived phenolic compounds,ANTIVIRAL RESEARCH,2005 Oct,1(68):36-42
SCI論文 項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、侯庭鏞(Tin-Yun Ho)*,Morin inhibited 12-O-tetradecanoylphorbol- 13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression.,BIOCHEMICAL PHARMACOLOGY,2005 Jun,11(69):1603-1611
SCI論文 項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、侯庭鏞(Tin-Yun Ho)*,Activation of activator protein 1 and extracellular signal-regulated kinases in human hepatocellular transformation,TUMOR BIOLOGY,2004 Sep,25(5):313-320
SCI論文 侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、鄭欣宜(Shin-Ei Cheng)、魏鷰驕(Yen-Chiao Wei)、黃珊萍(Shan-Ping Huang)、項千芸(Chien-Yun Hsiang)*,Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein,BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,2004 Jan,313(4):938-947
SCI論文 許昇峰(Hsu,Sheng-Feng)、林昭庚、劉旭然(Hsu-Jan Liu)、賴羿如(I-Lu Lai)、吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)*,Activation of activator protein 1 in cells exposed to electrical stimulation of various parameters used in electro-acupuncture therapy.,AMERICAN JOURNAL OF CHINESE MEDICINE,2003 Dec,31(6):967-975
SCI論文 侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、賴羿如、鄭庚申、高尚德(Kao,Shung-Te)、項千芸(Chien-Yun Hsiang)*,An in vitro system combined with an in-house quantitation assay for screening hepatitis C virus inhibitors.,ANTIVIRAL RESEARCH,2003 May,58(3):199-208
SCI論文 項千芸(Chien-Yun Hsiang)、賴羿如(I-Lu Lai)、趙德澂(De-Cheng Chao)、侯庭鏞(Tin-Yun Ho)*,Differential regulation of activator protein 1 activity by glycyrrhizin.,LIFE SCIENCES,2002 Feb,70(14):1643-1656
SCI論文 項千芸(Chien-Yun Hsiang)、謝慶良(Ching-Liang Hsieh)、吳世祿(Shih-Lu Wu)、賴羿如(I-Lu Lai)、侯庭鏞(Tin-Yun Ho)*,Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herpes simplex virus replication,AMERICAN JOURNAL OF CHINESE MEDICINE,2001 Nov,3-4(29):459-467
SCI論文 劉旭然(Hsu-Jan Liu)、許昇峰(Sheng-Feng Hsu)、(Chang-Chi Hsieh)、侯庭鏞(Tin-Yun Ho)、謝慶良(Ching-Liang Hsieh)、(Chin-Chuan Tsai)、林昭庚(Jaung-Geng Lin)*,The effectiveness of Tsu-San-Li (St-36) and Tai-Chung (Li-3) acupoints for treatment of acute liver damage in rats.,AMERICAN JOURNAL OF CHINESE MEDICINE,2001 Feb,29(2):221-226
Other論文 (Chang, J.T.)、(Su, L.T.)、侯庭鏞(Tin-Yun Ho)、(Wang, S.R.)*,Molecular cloning and sequence analysis of porcine endogenous retrovirus.,中華民國獸醫學會雜誌,2001 Feb,27(2):94-103
SCI論文 侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、項錦惠(Chin-Hui Hsiang)、張天傑(Tien-Jye Chang)、項千芸(Chien-Yun Hsiang)*,Identification of a DNA-binding domain and an active-site residue of pseudorabies virus DNase.,BIOCHEMICAL JOURNAL,2000 Mar,346(2):441-445
Other論文 (Chen, J.R.)、(Weng, C.N.)、侯庭鏞(Tin-Yun Ho)、(Cheng, I.C.)、(Lai, S.S.)*,Identification of the copper-zinc superoxide dismutase activity in Mycoplasma hyopneumoniae.,中華民國獸醫學會雜誌,2000 Jan,73(1):301-310
SCI論文 侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、(Chang, T.J.)、(Hsiang, C.H.)、(Chng, S.H.)、項千芸(Chien-Yun Hsiang)*,Pseudorabies virus early protein 0 trans-activates the TATA-associated promoter by stimulating the transcription initiation.,VIRUS RESEARCH,1999 May,61(1):77-86
Other論文 侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、(Hsiang, C.H.)、(Hou, B.H.)、項千芸(Chien-Yun Hsiang)*,Characterization and morphologic analysis of bovine serum albumin-loaded poly(DL-lactide-co-glycolide) microsphere.,中華民國獸醫學會雜誌,1998 Sep,24(3):128-134
SCI論文 吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)、(Chang, T.J.)*,Identification, expression, and characterization of the pseudorabies virus DNA-binding protein gene and gene product.,VIRUS RESEARCH,1998 Jul,56(1):1-9
SCI論文 項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)、(Hsiang, C.H.)、(Chang, T.J.)*,Recombinant pseudorabies virus DNase exhibits a RecBCD-like catalytic function.,BIOCHEMICAL JOURNAL,1998 Feb,330(1):55-59
Other論文 侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang)、(Chang, T.J.)*,Review: new trends in development of pseudorabies vaccines.,中華民國獸醫學會雜誌,1998 Jan,24(1):1-9
SCI論文 侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang)、(Hsiang, C.H.)、(Chang, T.J.)*,DNA vaccination induces a long-term antibody response and protective immunity against pseudorabies virus in mice.,ARCHIVES OF VIROLOGY,1998 Jan,143(1):115-125
SCI論文 (Wong, M.L.)*、侯庭鏞(Tin-Yun Ho)、(Huang, J.H.)、項千芸(Chien-Yun Hsiang)、(Chang, T.J.),Stimulation of type I DNA topoisomerase gene expression by pseudorabies virus.,ARCHIVES OF VIROLOGY,1997 Oct,142(10):2099-2105
SCI論文 項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)、(Chang, T.J.)*,Identification of a pseudorabies virus UL12 (deoxyribonuclease) gene.,GENE,1996 Oct,177(1-2):109-113
SCI論文 項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)、(Lin, C.H.)、(Wu, K.)、(Chang, T.J.)*,Analysis of upregulated cellular genes in pseudorabies virus infection: use of mRNA differential display.,JOURNAL OF VIROLOGICAL METHODS,1996 Oct,62(1):11-19
SCI論文 侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang)、張天傑(Tien-Jye Chang)*,Analysis of pseudorabies virus genes by cDNA sequencing.,GENE,1996 Oct,175(1-2):247-251
SCI論文 侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang)、(Wu, K.)、(Chang, T.J.)*,Rapid screening of pseudorabies virus-specific cDNAs from a cDNA library.,JOURNAL OF VIROLOGICAL METHODS,1996 Apr,58(1-2):187-192
Other論文 項千芸(Chien-Yun Hsiang)、侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、(Chang, T.J.)*,Cloning and sequencing of the ICP0 homologous gene of pseudorabies virus.,中華民國獸醫學會雜誌,1995 Dec,21(6):327-338
Other論文 侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、(Chang, T.J.)*,Cloning and analysis of pseudorabies virus DNA replication-independent transcripts.,中華民國獸醫學會雜誌,1995 Aug,21(4):201-211
 
研討會論文/Conference Papers
(發表主題或論文名稱,研討會名稱,演講地點,研討會期間,受邀演講題目)
1﹒ Analysis and Application of Leptin Receptor-Targeting Chinese Herbal Medicine,第34屆生物醫學聯合學術年會,Taipei,2019.3.23 ~ 2019.3.24,
2﹒ Analysis and Application of Leptin Receptor-Targeting Chinese Herbal Medicine,第34屆生物醫學聯合學術年會,國防醫學院,2019.3.23 ~ 2019.3.24,
3﹒ Antioxidant Capacity and Docking Analysis of Anthocyanin Derivatives as Anti-Inflammatory Agents,Asian Conference on Engineering and Natural Sciences / International Symposiumon Fundamental and Applied Sciences,Hokkaido, Japan,2019.1.22 ~ 2019.1.24,
4﹒ The analysis and research of anti-inflammatory peptides in Pinellia ternate,33屆生物醫學聯合學術年會,Taipei,2018.3.24 ~ 2018.3.25,
5﹒ Preliminary Transcriptomic Analysis of Gene Expression for The Potential Mechanism of Sheng Hua Tang on Uterus,The 10th Pong Ding Yuen International Symposium on Traditional Chinese Medicine,Hong Kong,2017.12.1 ~ 2017.12.3,
6﹒ A connective map for Semen Ziziphus jujube, gene, and insomnia by brain mRNA expression profiles in vivo,16th Meeting of Consortium for Globalization of Chinese Medicine (CGCM 2017),Guangzhou,2017.8.16 ~ 2017.8.17,
7﹒ Vanillin inhibited azoxymethane/dextran sulfate sodium-induced colorectal cancer in the mouse model,第32屆生物醫學聯合學術年會,國防醫學院,2017.3.25 ~ 2017.3.26,
8﹒ 從傳統醫學及芳香療法探討LS120中藥在水腫的調理效應及機轉分析,第85屆國醫節暨痺症臨床經驗學術研討會,台中,2015.3.29 ~ 2015.3.29,
9﹒ 長期照護機構中醫藥行為分析及泌尿道感染控制方法之探究-以洛神花為例,第85屆國醫節暨痺症臨床經驗學術研討會,台中,2015.3.29 ~ 2015.3.29,
10﹒ 利用全基因體微陣列技術探討生化湯對生殖系統之作用機轉,第四屆亞洲針灸高峰論壇,台中,2015.1.17 ~ 2015.1.18,
11﹒ Systems biology study on the heart protective and anti- heart failure efficacies of Chinese medicinal herbs,17th International Congress of Oriental Medicine,Taipei,2014.11.1 ~ 2014.11.3,
12﹒ Electroacupuncture improves trinitrobenzene sulphonic acid-induced colitis, evaluated by transcriptomic study,17th International Congress of Oriental Medicine,Taipei,2014.11.1 ~ 2014.11.3,
13﹒ Tracing anti-inflammatory effects of ginger and zingerone from organ to cell by NF-κB in vivo imaging,17th International Congress of Oriental Medicine,Taipei,2014.11.1 ~ 2014.11.3,
14﹒ Chinese herbal medicine Du-Huo (Radix AngelicaePubescentis.)has the function of anit-proliferation on A549,第七屆生物科技研討會,本校國際會議廳,2014.5.14 ~ 2014.5.14,
15﹒ 檳榔誘導單核球/巨噬細胞分化成蝕骨細胞之能力,第七屆生物科技研討會,本校國際會議廳,2014.5.14 ~ 2014.5.14,
16﹒ Study on the adjuvanticity of Chinese medicinal herb,The 29th Joint Conference of Biomedical Science,Taipei,2014.3.15 ~ 2014.3.16,
17﹒ Study on a novel Chinese medicinal formula that targets to heart failure,The 29th Joint Conference of Biomedical Science,Taipei,2014.3.15 ~ 2014.3.16,
18﹒ Antimicrobial susceptibility of vanillin against several Lactobacillus species isolated from swine guts at the western area of Taiwan.,「益生菌及代謝物之多重應用」學術與產業應用研討會暨台灣乳酸菌協會第五屆第二次會員大會,台灣大學凝態物理館2F國際會議廳,2013.11.22 ~ 2013.11.22,
19﹒ Therapeutic effect and mechanism of Zuo-Jin-Wan on hepatocellular carcinoma,The 9th International Postgraduate Symposium on Chinese Medicine,Hong Kong,2013.8.16 ~ 2013.8.16,
20﹒ Antimicrobial activity of vanillin to the emergence of antimicrobial resistance pathogens in clinical isolates.,第18屆細菌學研討會,惠蓀實驗林場,2013.8.29 ~ 2013.8.31,
21﹒ Anti-Cancer Effects of Coptis chinensis and Evodia rutaecarpa in HepG2 Cells and in an Orthotopic Intrahepatic Xenograft Model,第13屆國際毒理學研討會XIII International Congress of Toxicology,韓國挪威(Korea)首爾(Seoul),2013.6.30 ~ 2013.7.4,
22﹒ Cucurbitaceae: from food, herb, to drug discovery,International Forum on TCM 2013 Taiwan,Taichung,2013.3.9 ~ 2013.3.10,
23﹒ Anticancer effects and mechanisms of Zuo-Jin-Wan and its alkaloidal ingredients in vitro and in mice,International Forum on TCM 2013 Taiwan,Taichung,2013.3.9 ~ 2013.3.10,
24﹒ Application of bioactive database of traditional Chinese medicine on the therapeutic prediction, drug development, and safety evaluation,16th International Congress of Oriental Medicine,Seoul, Korea,2012.9.14 ~ 2012.9.16,
25﹒ Therapeutic efficacy and mechanism of phenolic compounds on the 5- fluorouracil-induced mucositis,Twentieth Symposium on Recent Advances in Cellular and Molecular Biology,Kaohsiung,2012.2.7 ~ 2012.2.9,
26﹒ 以基因體研究平台為基礎進行防治肝病相關中藥之研究,行政院衛生署中醫藥委員會100年度研究計畫成果發表會,台中市,2011.10.15 ~ 2011.10.16,
27﹒ New Translational medicine study of Chinese medicinal herbs for diabetes,International Symposium on Traditional Chinese Medicine 2011 & the 26th Symposium on Natural Product,Taichung,2011.10.29 ~ 2011.10.30,New Translational medicine study of Chinese medicinal herbs for diabetes
28﹒ Conserved charged amino acid residues in the extracellular region of sodium/iodide symporter are critical for iodide transport activity,Nineteenth Symposium on Recent Advances in Cellular and Molecular Biology,Kaohsiung,2011.2.10 ~ 2011.2.12,
29﹒ In vitro and in vivo bioluminescent imaging for the evaluation of anti-enterotoxigenic E. coli activity of Galla Chinensis,The 20th Annual Meeting of Taiwan Society of Microbiology,Taipei,2010.12.11 ~ 2010.12.12,
30﹒ ARISTOLOCHIC ACID SUPPRESSES DNA REPAIR AND TRIGGERS OXIDATIVE DNA DAMAGE IN HUMAN KIDNEY PROXIMAL TUBULAR CELLS,,第十二屆國際毒理學研討會 XII International Congress of Toxicology.,Spain (西班牙)的Barcelona (巴塞隆納),2010.7.19 ~ 2010.7.23,
31﹒ Study on the immunomodulation of Chinese medicinal herbs by functional genomic platform approaches,Symposium of the National Research Program for Genomic Medicine,Taipei,2010.3.14 ~ 2010.3.15,
32﹒ Drug Design for XRCC4 in Silico,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
33﹒ Reducing without Side Effects? A Novel Strategy for Designing the PPAR Agonists,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
34﹒ Is That Possible to Design the Versatile Inhibitors for H1N1, H5N1, H5N2, and H5N7 ?,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
35﹒ Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction ?,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
36﹒ Drug Design for KU86 in DNA Break Repair System,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
37﹒ What is the Key Point for Designing HER2 Inhibitors ?,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
38﹒ Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
39﹒ Drug Design for the Influenza A Virus Subtype H1N1,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
40﹒ Drug Design for AMP-Activated Protein Kinase Agonists in Silico,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
41﹒ A Novel Strategy for Designing Dual-target Inhibitors of KU86 and XRCC4,2nd International Conference on BioMedical Engineering and Informatics (BMEI'09),Tianjin, China,2009.10.17 ~ 2009.10.19,
42﹒ Functional Genomic Research Approach for Traditional Chinese Medicine,21st IUBMB and 12th FAOBMB International Congress of Biochemistry and Molecular Biology,Shanghai, china,2009.8.2 ~ 2009.8.7,Functional Genomic Research Approach for Traditional Chinese Medicine
43﹒ Toxicogenomic analysis of aristolochic acid in normal human kidney cells,第十屆國際環境誘變劑學會學術會議,義大利佛羅倫斯,2009.8.20 ~ 2009.8.25,
44﹒ Synthesis and biological evaluation on analogs of quinoclamine, an inhibitor of NF-κB,2009台灣藥學會藥物化學研討會,南投縣溪頭臺大實驗林,2009.6.28 ~ 2009.6.30,
45﹒ DNA晶片資料庫搭配活體即時性基因反應報導系統在新藥開發之應用,學研研發成果交流平台會,台北市,2009.4.30 ~ 2009.4.30,
46﹒ LPS-Induced TNF-β and IL-1β Production Is Inhibited by Menthone via NF-κB Signaling Pathway in HaCat Cells,第二屆中國醫藥大學暨亞洲大學生物科技研討會,立夫教學大樓B1國際會議廳,2009.3.16 ~ 2009.3.16,
47﹒ LPS-Induced Tumor Necrosis Factor-β and Interleukin-1β Production Is Inhibited by Menthone via Nuclear Factor-κB Signaling Pathway in HaCat Cells,第二十四屆生物醫學聯合學術年會,國防醫學院內湖院區,2009.3.21 ~ 2009.3.22,
48﹒ Nuclear Factor-kBBioluminescence Imaging-Guided Transcriptomic Analysis for the Assessment of Host-Ionizing Radiation Interaction in Vivo,中華民國放射線醫學會第26屆第3次會員大會暨第58次學術研討會,台中榮總,2009.3.28 ~ 2009.3.29,
49﹒ Nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis for the assessment of host-ionizing radiation interaction in vivo,The 58th Annual Meeting of the Radiological Society of the Republic of China,Taichung,2009.3.28 ~ 2009.3.29,
50﹒ Development a novo inhibitor of diarrhea from ginger components by virtual screening technique,第二屆中國醫藥大學暨亞洲大學生物科技研討會,立夫B1,2009.3.16 ~ 2009.3.16,
51﹒ DNA晶片技術在新藥開發應用之探討,九十七年度生物科技研發成果聯合發表會,台北市,2008.10.30 ~ 2008.10.30,
52﹒ HerbBLAST:中藥方劑查詢與相似性比對的一種全新工具,2008年第十一屆工程科技與中西醫藥應用研討會,台灣、台中,2008.6.15 ~ 2008.6.15,
53﹒ 苦瓜蛋白調整血糖機制及其應用之研究,苦瓜產業與保健功效研討會,花蓮市,2008.6.12 ~ 2008.6.12,
54﹒ 以大腸桿菌忌熱性腸毒素為標的開發中草藥抗下痢之高速篩選平台,2008研究學習群期末成果發表會,台中市,2008.6.6 ~ 2008.6.6,
55﹒ 開啟本草功能性基因體學新世代,台灣現代奈米本草綱目啟動,台中市,2008.6.6 ~ 2008.6.6,
56﹒ Novel PPAR-γ agonist identified from a phytochemical library of traditional Chinese medicine by docking analysis,2008工程科技與中西醫藥應用研討會,台中市,2008.6.15 ~ 2008.6.15,
57﹒ Novel PPAR-γ agonist identified from a phytochemical library of traditional Chinese medicine by docking analysis,2008研究學習群期末成果發表會,台中市,2008.6.6 ~ 2008.6.6,
58﹒ The Molecular Mechanism of Menthol in Human Keratinocytes,第一屆中國醫藥大學生物科技研討會,台中市,2008.4.7 ~ 2008.4.7,
59﹒ 基因影像與生物資訊在中醫藥之研究與應用,2008國際中醫藥學術研討會,中國醫藥大學立夫教學大樓B1國際會議廳,2008.3.29 ~ 2008.3.30,
60﹒ Research and development of Chinese medicinal herbs for anti-liver diseases by the genomic-based platform,Symposium of the National Research Program for Genomic Medicine,Taipei,2008.3.2 ~ 2008.3.3,
61﹒ The Molecular Mechanism of Menthol in Human Keratinocytes,第23屆生物醫學聯合學術年會,台北市,2008.3.28 ~ 2008.3.29,
62﹒ Establishment of the noninvasive nuclear factor-κB bioluminescence imaging and its application on the anti-inflammatory drug development,Sixteenth Symposium on Recent Advances in Cellular and Molecular Biology,Pingtung,2008.1.23 ~ 2008.1.25,
63﹒ Microarray analysis of vanillin-regulated gene expression profile in human hepatocarcinoma cells,The 14th International Congress of Oriental Medicine,Taipei,2007.12.2 ~ 2007.12.3,
64﹒ Search and identify anti-diarrheal phytochemicals from traditional Chinese medicines by molecular biology and bioinformatics tools,The 14th International Congress of Oriental Medicine,Taipei,2007.12.2 ~ 2007.12.3,
65﹒ Vanillin suppresses cell invasion through inhibiting matrix metalloproteinase-9 gene expression in HepG2 cells,The 1st International Cancer Symposium,Taichung,2007.11.16 ~ 2007.11.17,
66﹒ Vanillin suppresses cell invasion through inhibiting matrix metalloproteinase-9 gene expression in HepG2 cells,第一屆國際癌症學術研討會,中國醫藥大學,2007.11.16 ~ 2007.11.17,
67﹒ 搜尋308種中藥對氨基配醣類抗生素抗藥性大腸桿菌的相關活性研究,2007年第十屆工程科技與中西醫藥應用研討會,台中市,2007.5.27 ~ 2007.5.27,
68﹒ 中草藥抗菌在乳業之應用,中草藥應用於畜牧業之展望研討會,新竹,2007.4.30 ~ 2007.4.30,
69﹒ Extracellular conservative charged amino acid residues on the sodium iodide symporter responding for iodine uptake,The 22th Joint Annual Conference of Biomedical Sciences,Taipei,2007.3.17 ~ 2007.3.18,
70﹒ 枇杷葉及其主要成分物抑制肺部細胞發炎反應之探討,中華民國第六屆第三次會員大會暨學術研討會,台中市,2007.3.11 ~ 2007.3.11,
71﹒ 白虎湯在脂肪細胞加強胰島素促進葡萄糖吸收是經由PPARI的作用,第28屆中華民國內分泌暨糖尿病學會年會,台灣台北市,2007.3.17 ~ 2007.3.18,
72﹒ Roles of conserved charged amino acid residues of herpes simplex virus type 1 UL12 in nuclease activities and DNA-binding abilities,The 22th Joint Annual Conference of Biomedical Sciences,Taipei,2007.3.17 ~ 2007.3.18,
73﹒ 活體影像技術於生醫研究上的經驗分享,活體影像技術於生醫研究上的應用研習會,台中市,2007.1.25 ~ 2007.1.26,
74﹒ 木瓜影響大腸桿菌腸毒素與受體結合及其抗下痢作用機轉,九十四年度委辦研究計畫成果發表會暨第二十一屆天然藥物研討會,台灣台中,2006.12 ~ ,
75﹒ 木瓜影響大腸桿菌腸毒素與受體結合及其抗下痢作用機轉探討,行政院衛生署中醫藥委員會九十四年度委辦研究計畫成果發表會暨第二十一屆天然藥物研討會,台中,2006.11.18 ~ 2006.11.19,
76﹒ HerbBlast: A program for similarity and ontology analysis of Chinese herbal medicine,Bioinformatics in Taiwan 2006,Taichung,2006.9.13 ~ 2006.9.14,
77﹒ An analysis of herb recipes of cold-induced febrile diseases,2006第九屆工程科技與中西醫學應用研討會,台中市,2006.5.28 ~ 2006.5.28,
78﹒ An analysis of medical similarity between herb descriptions with example of Crocus Sativus,2006第九屆工程科技與中西醫學應用研討會,台中市,2006.5.28 ~ 2006.5.28,
79﹒ Automatic inference of herb application with ART neural network,2006第九屆工程科技與中西醫學應用研討會,台中市,2006.5.28 ~ 2006.5.28,
80﹒ Antifatigue effect and proteomics-based constituent analysis of deer antler,The Spring Symposium of the Taiwan Association of Veterinary Medi,Chaiyi,2006.5.13 ~ 2006.5.13,
81﹒ Berberine and its analogs suppressed pulmonary inflammation in vitro,2006第九屆工程科技與中西醫學應用研討會,台中市,2006.5.28 ~ 2006.5.28,
82﹒ Preventive and therapeutic effects of vanillin for trinitrobenzene sulfonic acid-induced colitis in mice,2006第九屆工程科技與中西醫學應用研討會,台中市,2006.5.28 ~ 2006.5.28,
83﹒ Acetaldehyde induces matrix metalloproteinase-9 gene expression via the activation of IκB and JNK/β-TrCP signaling pathways in HepG2 cells: association with the invasive potential.,Fourteenth Symposium on Recent Advances in Cellular and Molecular,Pingtung,2006.1.18 ~ 2006.1.20,
84﹒ Involvement of conserved histidine-141 and asparagne-251 residues of human endonuclease G in magnesium binding and enzyme activity.,Fourteenth Symposium on Recent Advances in Cellular and Molecular Biology,Pingtung,2006.1.18 ~ 2006.1.20,
85﹒ Synthesis of substituted benzyloxybenzoic acids as the inhibitor of ganglioside GM1 receptor.,2005 年中國藥學會藥物化學研討會,南投縣,2005.9.4 ~ 2005.9.6,
86﹒ 五倍子影響大腸桿菌腸毒素與受體結合及其下痢作用機轉探討,2005年第八屆中西醫藥應用與工程科技研討會,台中市,2005.5.28 ~ 2005.5.28,
87﹒ 黃連生物鹼類化合物抑制肺部相關細胞細胞炎症反應激素機制之探討,2005年第八屆中西醫藥應用與工程科技研討會,台中市,2005.5.28 ~ 2005.5.28,
88﹒ Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction,The Twentieth Joint Annual Conference of Biomedical Sciences,Taipei,2005.3.26 ~ 2005.3.27,
89﹒ Identification of amino acid residues of pseudorabies virus DNA-binding protein involved in strand invasion,The Twentieth Joint Annual Conference of Biomedical Sciences,Taipei,2005.3.26 ~ 2005.3.27,
90﹒ The growth regulation effects of silibinin on Chang liver cells,The Twentieth Joint Annual Conference of Biomedical Sciences,Taipei,2005.3.26 ~ 2005.3.27,
91﹒ Galla Chinensis and its tannins inhibited E. coli heat-labile enterotoxin induced diarrhea through blocking LT and GM1 interaction.,2004 Annual Meeting of Pharmaceutical Society and Proceedings of Conference on Pharmaceutical Scienc,Taipei,2004.12.18 ~ 2004.12.18,
92﹒ Identification in Chinese herb and confirm berberine that suppressed acetaldehyde-induced tumor necrosis factor-α and interleukin-1β expression via nu,2004 Conference on Engineering Technology and Applications on Chi,Taichung,2004.6.6 ~ 2004.6.6,
93﹒ Identification of Polygonaceae-derived Chinese herbs and compounds that inhibit the interaction between SARS-CoV spike protein and angiotensin-convert,2004 International Symposium on Functional Foods for Health in Ta,Taichung,2004.5.27 ~ 2004.5.27,
94﹒ Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.,The Nineteenth Joint Annual Conference of Biomedical Sciences,Taipei,2004.4.10 ~ 2004.4.11,
95﹒ Immunigenicity of BCG-Escherichia coli heat-labile enterotoxin subunit b conjugated vaccine in mice,The Nineteenth Joint Annual Conference of Biomedical Sciences,Taipei,2004.4.10 ~ 2004.4.11,
96﹒ Berberine suppressed acetaldehyde-induced tumor necrosis factor-α and interleukin-1β expression via nuclear factor-κB signaling pathway,Twelve Symposium on Recent Advances in Cellular and Molecular Bio,屏東,2004.2.2 ~ 2004.2.4,
97﹒ ,2003年第三屆兩岸中醫藥學術研討會,台北市,2003.12.21 ~ 2003.12.21,以中醫藥與基因體醫學為基礎開發及設計抗下痢藥之研究
98﹒ Establishment of the Escherichia coli heat-labile enterotoxin B subunit-based screening platform for studying the medicinal herbs with anti-diarrheal abilities,The 12th International Congress of Oriental Medicine,Taipei,2003.11.6 ~ 2003.11.9,
99﹒ Functional expression of SARS viral spike protein in Escherichia coli,2003 International Conference on Influenza and the Resurgence of Severe Acute Respiratory Syndrome,Taipei,2003.10.28 ~ 2003.10.31,
100﹒ Evodia rutaecarpa inhibits activator protein 1 transactivation and cell transformation in human hepatocytes,The Eighteenth Joint Annual Conference of Biomedical Sciences,Taipei,2003.3.22 ~ 2003.3.23,
101﹒ Screening the anti-diarrheal herbs by using Escherichia coli heat-labile enterotoxin B subunit as the target,The Eighteenth Joint Annual Conference of Biomedical Sciences,Taipei,2003.3.22 ~ 2003.3.23,
102﹒ Effects of macrolides on the activator protein 1 and nuclear factor-κB activities.,The Eighteenth Joint Annual Conference of Biomedical Sciences,Taipei,2003.3.22 ~ 2003.3.23,
103﹒ Study on the molecular mechanism and therapeutic efficacy of flavonoids for hepatocellular transformation,Screening the anti-diarrheal herbs by using Escherichia coli heat-labile enterotoxin B subunit as th,Pintung,2002.1.25 ~ 2002.1.28,
104﹒ Regulation of gene transcription by Chinese herbs in hepatocytes.,The 11th international congress of oriental medicine,Korea,2001.10.11 ~ 2001.10.14,
 
專書/Books
(作者,書名,出版商,出版日期)
1﹒ 鍾景光(Jing-Gung Chung)*、侯庭鏞(Tin-Yun Ho)、林麗娟(Li-Jen Lin)、林靖婷(Ching-Ting Lin)、江素瑛(Su-yin Chiang)、項千芸(Chien-Yun Hsiang)、吳琇卿(Wu,Hsiu-Ching)、羅欣宜、魏維彥、陳雅吟、李佩怡、許博期,系統生物學與中醫藥研發,中國醫藥大學,2013.11
2﹒ 吳錫金(Wu,Hsi-Chin)、侯庭鏞(Tin-Yun Ho)、方世華、林振文(Lin Cheng Wen)、項千芸(Chien-Yun Hsiang)、李龍緣(Long-Yuan Li)、林應如(Ying-Ju Lin)、許晉銓(Jinn-Chyuan Sheu)、萬磊(Lei Wan)、徐媛曼(Yuan-Man Hsu)、洪千惠、湯智昕(Tang Chih-Hsin)、賴怡琪、賴志河(Chih-Ho Lai),Arthur M. Lesk: Introduction to Bioinformatics,,2008.9
 
研究計畫/Research Grant
(研究類型,研究計畫代號,主持人,補助或委託單位名稱,計畫名稱,研究經費,計畫期間)
1﹒ 個別型,MOST 108-2320-B-039-032-MY3,項千芸,侯庭鏞、鄭慧滿(Hui-Man Cheng),科技部,以IL-17/IL-17R為標靶之中草藥及其活性成分在乾癬的基礎及應用研究,$1050000,2021.8.1 ~ 2022.7.31
2﹒ 個別型,CMU109-MF-103,侯庭鏞(Ho, Tin-Yun),本校(含附醫),栝樓胰島素受體標靶胜肽對胰島素抗性之基礎與應用研究,$280000,2020.9.8 ~ 2021.7.31
3﹒ 個別型,MOST 107-2320-B-039-029-MY3,侯庭鏞,項千芸,科技部,天花粉胰島素受體標靶胜肽緩解胰島素抗性之研究與應用,$1000000,2020.8.1 ~ 2021.7.31
4﹒ 個別型,MOST 108-2320-B-039-032-MY3,項千芸,侯庭鏞、鄭慧滿(Hui-Man Cheng),科技部,以IL-17/IL-17R為標靶之中草藥及其活性成分在乾癬的基礎及應用研究,$1000000,2020.8.1 ~ 2021.7.31
5﹒ 學生參與計畫,CMU109-SR-18,侯庭鏞(Ho, Tin-Yun),本校(含附醫),以血管收縮素轉化酶C-domain為標靶之活性胜肽的開發及應用,$35000,2020.8.1 ~ 2021.2.28
6﹒ 學生參與計畫,109-2813-C-039-023-B,侯庭鏞(Ho, Tin-Yun),科技部,以血管收縮素轉化酶C-domain為標靶之活性胜肽的開發及應用,$48000,2020.7.1 ~ 2021.2.28
7﹒ 個別型,CMU108-MF-82,侯庭鏞,本校(含附醫),栝樓胰島素受體標靶胜肽對胰島素抗性之基礎與應用研究,$300000,2019.9.9 ~ 2020.7.31
8﹒ 個別型,MOST 107-2320-B-039-029-MY3,侯庭鏞,項千芸,科技部,天花粉胰島素受體標靶胜肽緩解胰島素抗性之研究與應用,$1000000,2019.8.1 ~ 2020.7.31
9﹒ 學生參與計畫,CMU108-SR-63,侯庭鏞,本校(含附醫),以血管收縮素轉換酶為標靶之降血壓藥物新設計概念驗證,$35000,2019.8.1 ~ 2020.2.28
10﹒ 個別型,NA,侯庭鏞,項千芸,教育部,中醫藥現代生技產業創新應用及服務開發,$4000000,2019.8.1 ~ 2020.7.31
11﹒ 個別型,MOST 108-2320-B-039-032-MY3,項千芸,侯庭鏞、鄭慧滿(Hui-Man Cheng),科技部,以IL-17/IL-17R為標靶之中草藥及其活性成分在乾癬的基礎及應用研究,$1170000,2019.8.1 ~ 2020.7.31
12﹒ 學生參與計畫,108-2813-C-039-090-B,侯庭鏞,科技部,以血管收縮素轉換酶為標靶之降血壓藥物新設計概念驗證,$48000,2019.7.1 ~ 2020.2.28
13﹒ 個別型,CMU104-H-02,項千芸,侯庭鏞,本校(含附醫),NIM之臨床前研究―NIM基因之選殖及確認、NIM蛋白之大量合成、NIM蛋白之化學合成,$200000,2018.11.1 ~ 2019.7.31
14﹒ 個別型,CMU104-H-01,侯庭鏞,項千芸,本校(含附醫),NIM之臨床前研究―體外生物活性探究、體內生物活性探究、藥動及活體分佈、臨床觀察,$1500000,2018.11.1 ~ 2019.7.31
15﹒ 個別型,MOST 105-2320-B-039-017-MY3,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,以腫瘤促發炎階段為抗癌標靶之中草藥效用、機轉及其應用研究,$1300000,2018.8.1 ~ 2019.7.31
16﹒ 個別型,MOST 107-2320-B-039-029-MY3,侯庭鏞,項千芸,科技部,天花粉胰島素受體標靶胜肽緩解胰島素抗性之研究與應用,$1000000,2018.8.1 ~ 2019.7.31
17﹒ 個別型,MOST104-2320-B-039-018-MY3,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),科技部,天花粉胰島素受體結合蛋白―由結構功能到臨床應用之研究,$1600000,2017.8.1 ~ 2018.7.31
18﹒ 個別型,CMU104-H-02,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),本校(含附醫),NIM之臨床前研究―NIM基因之選殖及確認、NIM蛋白之大量合成、NIM蛋白之化學合成,$1500000,2017.8.1 ~ 2018.7.31
19﹒ 個別型,CMU104-H-01,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),本校(含附醫),NIM之臨床前研究―體外生物活性探究、體內生物活性探究、藥動及活體分佈、臨床觀察,$3000000,2017.8.1 ~ 2018.7.31
20﹒ 個別型,MOST 105-2320-B-039-017-MY3,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,以腫瘤促發炎階段為抗癌標靶之中草藥效用、機轉及其應用研究,$1100000,2017.8.1 ~ 2018.7.31
21﹒ 學生參與計畫,CMU106-SR-31,侯庭鏞(Tin-Yun Ho),本校(含附醫),探討玉米鬚胜肽CS-1調降血壓之療效及機轉,$35000,2017.8.1 ~ 2018.2.28
22﹒ 學生參與計畫,106-2813-C-039-031-B,侯庭鏞(Tin-Yun Ho),科技部,探討玉米鬚胜肽CS-1調降血壓之療效及機轉,$48000,2017.7.1 ~ 2018.2.28
23﹒ 個別型,MOST104-2320-B-039-018-MY3,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),科技部,天花粉胰島素受體結合蛋白―由結構功能到臨床應用之研究,$1550000,2016.8.1 ~ 2017.7.31
24﹒ 個別型,CMU104-H-02,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),本校(含附醫),NIM之臨床前研究―NIM基因之選殖及確認、NIM蛋白之大量合成、NIM蛋白之化學合成,$1500000,2016.8.1 ~ 2017.7.31
25﹒ 個別型,CMU104-H-01,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),本校(含附醫),NIM之臨床前研究―體外生物活性探究、體內生物活性探究、藥動及活體分佈、臨床觀察,$3000000,2016.8.1 ~ 2017.7.31
26﹒ 個別型,MOST 105-2320-B-039-017-MY3,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,以腫瘤促發炎階段為抗癌標靶之中草藥效用、機轉及其應用研究,$1200000,2016.8.1 ~ 2017.7.31
27﹒ 國家型,MOST 105-2325-B-039-004-,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),科技部,新穎糖尿病胜肽藥物之臨床前研究,$2793000,2016.5.1 ~ 2017.4.30
28﹒ 個別型,MOST 104-2320-B-039-018-MY3,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),科技部,天花粉胰島素受體結合蛋白―由結構功能到臨床應用之研究,$1600000,2015.8.1 ~ 2016.7.31
29﹒ 個別型,CMU104-H-02,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),本校(含附醫),NIM之臨床前研究―NIM基因之選殖及確認、NIM蛋白之大量合成、NIM蛋白之化學合成,$2000000,2015.8.1 ~ 2016.7.31
30﹒ 個別型,CMU104-H-01,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),本校(含附醫),NIM之臨床前研究―體外生物活性探究、體內生物活性探究、藥動及活體分佈、臨床觀察,$4000000,2015.8.1 ~ 2016.7.31
31﹒ 整合型項下子計畫(主持人),NSC 102-2632-B-039-001-MY3,侯庭鏞(Tin-Yun Ho),科技部,中醫用藥抗老化醫學之研究與應用,$617500,2015.8.1 ~ 2016.7.31
32﹒ 整合型項下子計畫(主持人),2-4,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),教育部,中醫藥研究中心(中草藥研究群組),$2000000,2015.1.1 ~ 2015.12.31
33﹒ 個別型,NSC101-2320-B-039-034-MY3,侯庭鏞(Tin-Yun Ho),黃慧琪(Hui-Chi Huang)、項千芸(Chien-Yun Hsiang),科技部,慢性發炎相關疾病活體分子影像報導動物模式之構築、機轉分析及其在抗發炎中草藥研發之應用研究,$1230000,2014.8.1 ~ 2015.7.31
34﹒ 整合型項下子計畫(主持人),NSC 102-2632-B-039-001-MY3,侯庭鏞(Tin-Yun Ho),科技部,中醫用藥抗老化醫學之研究與應用-子計畫五,$617500,2014.8.1 ~ 2015.7.31
35﹒ 個別型,DMR-104-022,廖芳儀(Fang-I Liao),侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang),附醫院內計畫,由臨床到基礎分析生化湯對下視丘、卵巢、子宮之多器官多基因靶點研究--探討生化湯對於活體的生物效用,$300000,2014.8.1 ~ 2015.7.31
36﹒ 國家型,MOST 103-2325-B-039-002,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,新穎糖尿病胜藥物之研究(3/3),$2579000,2014.5.1 ~ 2015.4.30
37﹒ 校內其他單位控管計畫(例如:教卓計畫),NA,吳永昌(Yang-Chang Wu),郭盛助(Sheng-Chu Kuo)、林欣榮(Shinn-Zong Lin)、韓鴻志(Horng-Jyh Harn)、張建國(Jan-Gowth Chang)、林振文(Lin Cheng Wen)、湯智昕(Tang Chih-Hsin)、郭悅雄(Yueh-Hsiung Kuo)、陳悅生(Yueh-Sheng Chen)、林文川(Wen-Chuan Lin)、陳珠璜(Chu-Huang Chen)、林應如(Ying-Ju Lin)、侯庭鏞(Tin-Yun Ho)、顏宏融(Hung-Rong Yen),教育部,中醫藥研究中心(中草藥研究群組),$17100000,2014.4.1 ~ 2014.12.31
38﹒ 產學合作,102426BM,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),財團法人農業科技研究院,新型可專利性黏膜佐劑的建立與應用,$1500000,2014.3.18 ~ 2014.11.30
39﹒ 個別型,CMU102-NSC-04,侯庭鏞(Tin-Yun Ho),本校(含附醫),人中白 (KWLL)對於塵誘發的氣喘小鼠之免疫調控研究,$100000,2013.9.1 ~ 2014.7.31
40﹒ 個別型,NSC101-2320-B-039-034-MY3,侯庭鏞(Tin-Yun Ho),黃慧琪(Hui-Chi Huang)、項千芸(Chien-Yun Hsiang),科技部,慢性發炎相關疾病活體分子影像報導動物模式之構築、機轉分析及其在抗發炎中草藥研發之應用研究,$1230000,2013.8.1 ~ 2014.7.31
41﹒ 整合型項下子計畫(主持人),NSC 102-2632-B-039-001-MY3,侯庭鏞(Tin-Yun Ho),科技部,中醫用藥抗老化醫學之研究與應用-子計畫五,$617499,2013.8.1 ~ 2014.7.31
42﹒ 國家型,NSC102-2325-B-039-007,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,新穎糖尿病胜肽藥物之研究 (2/3),$2565000,2013.5.1 ~ 2014.4.30
43﹒ 產學合作,101426AM,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),財團法人台灣動物科技研究所,新型佐劑之開發及應用,$1800000,2013.4.10 ~ 2013.11.30
44﹒ 個別型,CMU101-S-21,侯庭鏞(Tin-Yun Ho),本校(含附醫),血糖調整中醫藥製劑之療效、機轉、及活性物質的分析 (2/3),$220000,2012.8.1 ~ 2013.7.31
45﹒ 個別型,100-2320-B-039-027-MY2,謝慶良(Ching-Liang Hsieh),侯庭鏞(Tin-Yun Ho)、唐娜櫻(Nou-Ying Tang)、林以文(Lin Yi-Wen)、程錦宜,,以基因體、電氣生理及分子生物學層次探討電針治療神經性痛之療效及其機轉,$950000,2012.8.1 ~ 2013.7.31
46﹒ 個別型,NSC101-2320-B-039-034-MY3,侯庭鏞(Tin-Yun Ho),黃慧琪(Hui-Chi Huang)、項千芸(Chien-Yun Hsiang),科技部,慢性發炎相關疾病活體分子影像報導動物模式之構築、機轉分析及其在抗發炎中草藥研發之應用研究,$1230000,2012.8.1 ~ 2013.7.31
47﹒ 個別型,NSC 101-2320-B-039-022,江素瑛(Su-yin Chiang),侯庭鏞(Tin-Yun Ho)、陳雅吟,科技部,以活體影像與基因晶片探討中醫健保前四大治療腎病的方劑與單味藥對小鼠急性與慢性馬兜鈴酸腎病之療效機轉,$900000,2012.8.1 ~ 2013.7.31
48﹒ 非研究型計畫 (例如:課程計畫),NSC 100-2811-B-039-018,許游章(You-Cheng Hseu),王升陽、侯庭鏞(Tin-Yun Ho),科技部,台灣薑科普來氏月桃及活性成分對抗鱗狀上皮細胞癌及預防紫外線誘導皮膚老化、發炎與皮膚癌之研究:利用多種不同生物活性機能系統評估及分子機制之探討,$878274,2012.8.1 ~ 2013.7.31
49﹒ 個別型,NSC 99-2320-B-039-035-MY3,許游章(You-Cheng Hseu),王升陽、侯庭鏞(Tin-Yun Ho),科技部,台灣薑科普來氏月桃及活性成分對抗鱗狀上皮細胞癌及預防紫外線誘導皮膚老化、發炎與皮膚癌之研究:利用多種不同生物活性機能系統評估及分子機制之探討,$1226000,2012.8.1 ~ 2013.7.31
50﹒ 個別型,NSC100-2320-B-039-027-MY2,謝慶良(Ching-Liang Hsieh),侯庭鏞(Tin-Yun Ho)、唐娜櫻(Nou-Ying Tang)、林以文(Lin Yi-Wen)、程錦宜(Chin-Yi Cheng),科技部,以基因體、電氣生理及分子生物學層次探討電針治療神經性痛之療效及其機轉,$950000,2012.8.1 ~ 2013.7.31
51﹒ 國家型,NSC 101-2325-B-039-007,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,新穎糖尿病胜肽藥物之研究 (1/3),$2500000,2012.5.1 ~ 2013.4.30
52﹒ 個別型,CCMP101-RD-103,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang)、李采娟(Tsai-Chung Li)、黃慧琪(Hui-Chi Huang),衛福部,糖尿病新型中醫藥之轉譯醫學研究 (2-2),$1000000,2012.1.16 ~ 2012.12.15
53﹒ 非研究型計畫 (例如:課程計畫),NSC 98-2320-B-039-037-MY3,楊新玲(Yang Hsin-ling),侯庭鏞(Tin-Yun Ho),科技部,香杉芝抗癌、抗發炎、抗轉移及抗血管新生之保健機能探討:利用多種不同生物活性機能系統評估(擴增計劃專任助理-陳智聖),$465101,2011.9.1 ~ 2012.7.31
54﹒ 個別型,CMU100-S-34,侯庭鏞(Tin-Yun Ho),本校(含附醫),血糖調整中醫藥製劑之療效、機轉、及活性物質的分析,$260000,2011.8.1 ~ 2012.7.31
55﹒ 個別型,NSC 100-2320-B-039 -016 -,江素瑛(Su-yin Chiang),侯庭鏞(Tin-Yun Ho)、陳雅吟(Chen Ya-Yin),科技部,以活體影像與基因晶片探討健保前四大治療腎病的中醫方劑對小鼠馬兜鈴酸腎病之療效機轉,$800000,2011.8.1 ~ 2012.7.31
56﹒ 個別型,NSC 100-2324-B-039-001,侯庭鏞(Tin-Yun Ho),林民昆(Lin, Ming-Kuem)、項千芸(Chien-Yun Hsiang)、劉昌宇,科技部,植物瘦肉蛋白生技飼料添加物之研發與應用,$1850000,2011.8.1 ~ 2012.7.31
57﹒ 個別型,NSC 100-2320-B-039 -020 -,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho)、黃慧琪(Hui-Chi Huang),科技部,黃耆及其活性成分增強肺黏膜sIgA表現的機轉及其應用之研究,$900000,2011.8.1 ~ 2012.7.31
58﹒ 個別型,NSC100-2320-B-039-027-MY2,謝慶良(Ching-Liang Hsieh),侯庭鏞(Tin-Yun Ho)、唐娜櫻(Nou-Ying Tang)、林以文(Lin Yi-Wen)、程錦宜(Chin-Yi Cheng),科技部,以基因體、電氣生理及分子生物學層次探討電針治療神經性痛之療效及其機轉,$950000,2011.8.1 ~ 2012.7.31
59﹒ 個別型,100-2320-B-039-027-MY2,謝慶良(Ching-Liang Hsieh),侯庭鏞(Tin-Yun Ho)、唐娜櫻(Nou-Ying Tang)、林以文(Lin Yi-Wen)、程錦宜,,以基因體、電氣生理及分子生物學層次探討電針治療神經性痛之療效及其機轉,$950000,2011.8.1 ~ 2012.7.31
60﹒ 個別型,NSC 99-2320-B-039-035-MY3,許游章(You-Cheng Hseu),王升陽、侯庭鏞(Tin-Yun Ho),科技部,台灣薑科普來氏月桃及活性成分對抗鱗狀上皮細胞癌及預防紫外線誘導皮膚老化、發炎與皮膚癌之研究:利用多種不同生物活性機能系統評估及分子機制之探討,$1203000,2011.8.1 ~ 2012.7.31
61﹒ 個別型,CCMP 100-RD-048,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang)、李采娟(Tsai-Chung Li)、黃慧琪(Hui-Chi Huang),衛福部,糖尿病新型中醫藥之轉譯醫學研究 (2-1),$900000,2011.7.19 ~ 2011.12.31
62﹒ 國家型,NSC99-2323-B-039-003,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,糖尿病胜肽新藥之最適化研究,$1300000,2010.11.1 ~ 2011.7.31
63﹒ 個別型,NSC 98-2320-B-039-030-MY2,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,以新穎活性分析平台研究抗腸毒性大腸桿菌下痢之中草藥及其活性成分,$750000,2010.8.1 ~ 2011.7.31
64﹒ 個別型,NSC 97-2320-B-039-012-MY3,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),科技部,應用NUCLEAR FACTOR-ΚB活體分子影像進行抗發炎中草藥之研究,$1121000,2010.8.1 ~ 2011.7.31
65﹒ 學生參與計畫,CMU99-大專-48,侯庭鏞(Tin-Yun Ho),本校(含附醫),臨床糖尿病治療藥物對全身性葡萄糖代謝關鍵基因-PPAR之活體效應研究,$35000,2010.8.1 ~ 2011.2.28
66﹒ 個別型,NSC 99-2324-B-039-002,侯庭鏞(Tin-Yun Ho),林民昆(Lin, Ming-Kuem)、吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang)、靳子蓉(Tzyy-Rong Jinn),科技部,植物瘦肉蛋白生技飼料添加物之研發,$1500000,2010.8.1 ~ 2011.7.31
67﹒ 個別型,NSC 99-2320-B-039-035-MY3,許游章(You-Cheng Hseu),王升陽、侯庭鏞(Tin-Yun Ho),科技部,台灣薑科普來氏月桃及活性成分對抗鱗狀上皮細胞癌及預防紫外線誘導皮膚老化、發炎與皮膚癌之研究:利用多種不同生物活性機能系統評估及分子機制之探討,$1203000,2010.8.1 ~ 2011.7.31
68﹒ 學生參與計畫,CMU99-大專-39,江素瑛(Su-yin Chiang),侯庭鏞(Tin-Yun Ho)、吳琇卿(Wu,Hsiu-Ching),本校(含附醫),利用Nuclear factor-kB 活體分子影像探討游離輻射損傷與中草藥或其有效成分之輻射保護作用,$35000,2010.7.1 ~ 2011.2.28
69﹒ 學生參與計畫,NSC 99-2815-C-039-048-B,侯庭鏞(Tin-Yun Ho),科技部,臨床糖尿病治療藥物對全身性葡萄糖代謝關鍵基因-PPAR之活體效應研究,$47000,2010.7.1 ~ 2011.2.28
70﹒ 國家型,CCMP97-RD-201,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、陳光偉(Chen, G.W.),衛福部,利用功能性基因體學平台為基礎進行中藥免疫調控之研究,$2366506,2010.5.1 ~ 2011.4.30
71﹒ 個別型,NSC 98-2320-B-039-030-MY2,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho),科技部,以新穎活性分析平台研究抗腸毒性大腸桿菌下痢之中草藥及其活性成分,$800000,2009.8.1 ~ 2010.7.31
72﹒ 個別型,NSC 98-2324-B-039-004,項千芸(Chien-Yun Hsiang),陳清助(Ching-Chu Chen)、吳世祿(Shih-Lu Wu)、侯庭鏞(Tin-Yun Ho),科技部,以具調控血糖功效之瓜科蛋白質為導引進行調整代謝產品的開發,$1000000,2009.8.1 ~ 2010.7.31
73﹒ 個別型,NSC 97-2320-B-039-012-MY3,侯庭鏞(Tin-Yun Ho),吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang),科技部,應用NUCLEAR FACTOR-ΚB活體分子影像進行抗發炎中草藥之研究,$1121000,2009.8.1 ~ 2010.7.31
74﹒ 學生參與計畫,CMU98-大專-71,侯庭鏞(Tin-Yun Ho),本校(含附醫),栝樓類中藥應用於血糖調整之療效、機轉、及活性物質的分析,$30000,2009.8.1 ~ 2010.2.28
75﹒ 個別型,NSC 98-2320-B-039-037-MY3,楊新玲(Yang Hsin-ling),侯庭鏞(Tin-Yun Ho),科技部,香杉芝抗癌、抗發炎、抗轉移及抗血管新生之保健機能探討:利用多種不同生物活性機能系統評估,$850000,2009.8.1 ~ 2010.7.31
76﹒ 學生參與計畫,NSC 98-2815-C-039-071-B,侯庭鏞(Tin-Yun Ho),科技部,栝樓類中藥應用於血糖調整之療效、機轉、及活性物質的分析,$47000,2009.7.1 ~ 2010.2.28
77﹒ 國家型,CCMP97-RD-201,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、陳光偉(Chen, G.W.),衛福部,利用功能性基因體學平台為基礎進行中藥免疫調控之研究,$2354131,2009.5.1 ~ 2010.4.30
78﹒ 個別型,DMR-98-001,謝慶良(Ching-Liang Hsieh),侯庭鏞(Tin-Yun Ho)、唐娜櫻(Nou-Ying Tang),附醫院內計畫,利用Nuclear factor-kB 活體分子影像探討天麻和它的成份Vanillyl alcohol 抗癲癇之研究,$200000,2009.1.7 ~ 2009.12.31
79﹒ 個別型,NSC 97-2320-B-039-012-MY3,侯庭鏞(Tin-Yun Ho),吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang),科技部,應用NUCLEAR FACTOR-ΚB活體分子影像進行抗發炎中草藥之研究,$1121000,2008.8.1 ~ 2009.7.31
80﹒ 學生參與計畫,CMU97-064,侯庭鏞(Tin-Yun Ho),本校(含附醫),生物資訊在傷寒方的應用 - 傷寒方組方邏輯之探討,$30000,2008.8.1 ~ 2009.2.28
81﹒ 個別型,CMU97-CMC-004,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang),本校(含附醫),調整血糖活性之中醫藥新藥開發,$700000,2008.8.1 ~ 2009.7.31
82﹒ 學生參與計畫,NSC 97-2815-C-039-061-B,侯庭鏞(Tin-Yun Ho),科技部,生物資訊在傷寒方的應用 - 傷寒方組方邏輯之探討,$47000,2008.7.1 ~ 2009.2.28
83﹒ 國家型,CCMP97-RD-201,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho)、吳世祿(Shih-Lu Wu)、陳光偉(Chen, G.W.),衛福部,利用功能性基因體學平台為基礎進行中藥免疫調控之研究,$2098381,2008.5.1 ~ 2009.4.30
84﹒ 國家型,CCMP96-RD-201,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、包大?(Da-Tian Bau),衛福部,以基因體研究平台為基礎進行防治肝病相關中藥之研究,$2000000,2008.5.1 ~ 2009.4.30
85﹒ 國家型,NSC 97-2317-B-039-002,項千芸(Chien-Yun Hsiang),侯庭鏞(Tin-Yun Ho)、陳清助(Ching-Chu Chen)、吳世祿(Shih-Lu Wu),科技部,苦瓜蛋白調整血糖機制及其應用之研究 (2/2),$1920000,2008.1.1 ~ 2008.12.31
86﹒ 個別型,NSC 96-2320-B-039-019,侯庭鏞(Tin-Yun Ho),吳世祿(Shih-Lu Wu)、項千芸(Chien-Yun Hsiang),科技部,以NF-KB活性為核心之全身性與系統性基因表現圖譜應用於中醫肝病方藥之研究,$876000,2007.8.1 ~ 2008.7.31
87﹒ 個別型,DMR-97-103,高嘉鴻(Chia-Hung Kao),侯庭鏞(Tin-Yun Ho),附醫院內計畫,以鈉-碘運送子基因為基礎之放射性碘治療合併去氧核糖核酸抑制劑Zebularine於肝癌細胞株之效益評估,$200000,2007.8.1 ~ 2008.7.31
88﹒ 個別型,DMR-97-104,孫盛生(Shung-Shung Sun),侯庭鏞(Tin-Yun Ho),附醫院內計畫,NF-B為基礎之分子影像分析運用於藥物誘發之肝毒性篩檢之可行性評估 Evaluation of NF-B-based molecular image in the application of drug-induced hepatotoxicity,$200000,2007.8.1 ~ 2008.7.31
89﹒ 個別型,DMR-96-109,蘇珊玉(Shan-Yu Su),謝慶良(Ching-Liang Hsieh)、侯庭鏞(Tin-Yun Ho),附醫院內計畫,利用冷光劑測定法探討丹蔘酮2A在SH-SY5Y細胞中對過氧化氫造成的氧化傷害中NkappaB活化的影響,$250000,2007.8.1 ~ 2008.7.31
90﹒ 國家型,CCMP 96-RD-201,侯庭鏞(Tin-Yun Ho),包大?(Da-Tian Bau)、項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu),衛福部,以基因體研究平台為基礎進行防治肝病相關中藥之研究,$3800000,2007.5.1 ~ 2009.4.30
91﹒ 國家型,CCMP96-RD-201,侯庭鏞(Tin-Yun Ho),項千芸(Chien-Yun Hsiang)、吳世祿(Shih-Lu Wu)、包大?(Da-Tian Bau),衛福部,以基因體研究平台為基礎進行防治肝病相關中藥之研究,$1800000,2007.5.1 ~ 2008.4.30
92﹒ 國家型,NSC 96-2317-B-039-001,項千芸(Hsiang,Chien-Yun),陳清助(Ching-Chu Chen)、侯庭鏞(Ho,Tin-Yun)、吳世祿(Wu,Shih-Lu),科技部,苦瓜蛋白調整血糖機制及其應用之研究 (1/2),$1850000,2007.1.1 ~ 2007.12.31
93﹒ 個別型,NSC 95-2320-B-039 -004,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun)、吳世祿(Wu,Shih-Lu)、高尚德(Kao,Shung-Te),科技部,中醫方劑抑制C型肝炎病毒肝病病程之療效機轉研究 (2/2),$1033000,2006.8.1 ~ 2007.7.31
94﹒ 個別型,CMU95-055,項千芸(Hsiang,Chien-Yun),侯庭鏞(Ho,Tin-Yun)、吳世祿(Shih-Lu Wu),本校(含附醫),以泡疹病毒去氧核醣核酸分解酵素作為新穎標的進行中草藥抗病毒的研究,$400000,2006.8.1 ~ 2007.7.31
95﹒ 個別型,CMU95-053,侯庭鏞(Ho,Tin-Yun),吳世祿(Wu,Shih-Lu)、項千芸(Chien-Yun Hsiang),本校(含附醫),以新穎活性分析平台開發中草藥抗腸毒素性下痢之新藥,$500000,2006.8.1 ~ 2007.7.31
96﹒ 個別型,NSC95-2320-B-039-033,謝慶良(Hsieh,Ching-Liang),侯庭鏞(Ho,Tin-Yun)、唐娜櫻(Tang,Nou-Ing),科技部,Cytokine和NF-κB在鉤藤抗癲癇作用不同時間點的角色,$1012000,2006.8.1 ~ 2007.7.31
97﹒ 個別型,DMR-96-065,高嘉鴻(Chia-Hung Kao),侯庭鏞(Tin-Yun Ho),附醫院內計畫,於大腸癌細胞株SW480中,經由鈉鉀轉運分子所調節之轉殖表現TPO基因是否會增加放射性碘在癌細胞內之攝取及滯留-可對大腸癌的放射治療提供一個新的方式,$208000,2006.7.1 ~ 2007.6.30
98﹒ 個別型,DMR-96-066,孫盛生(Shung-Shung Sun),高嘉鴻(Chia-Hung Kao)、侯庭鏞(Tin-Yun Ho),附醫院內計畫,探討ATRA刺激乳癌細胞株MCF-7表現鈉碘轉運分子的機制,$178000,2006.7.1 ~ 2007.6.30
99﹒ 國家型,95農科-6.2.1-科-a1(16),項千芸(Hsiang,Chien-Yun),陳清助(Ching-Chu Chen)、侯庭鏞(Ho,Tin-Yun)、吳世祿(Wu,Shih-Lu),農委會,苦瓜調整血糖有效成分、功能性基因分離鑑定及其應用之研究,$800000,2006.1.1 ~ 2006.12.31
100﹒ 個別型,95農科-6.2.1-科-A1(16),項千芸(Hsiang,Chien-Yun),陳清助(Ching-Chu Chen)、侯庭鏞(Ho,Tin-Yun)、吳世祿(Wu,Shih-Lu),農委會,苦瓜調整血糖有效成分、功能性基因分離鑑定及其應用之研究,$800000,2006.1.1 ~ 2006.12.31
101﹒ 個別型,NSC 94-2320-B-039-021,侯庭鏞(Ho,Tin-Yun),吳世祿(Wu,Shih-Lu)、項千芸(Hsiang,Chien-Yun)、高尚德(Kao,Shung-Te),科技部,中醫方劑抑制C型肝炎病毒肝病病程之療效機轉研究 (1/2),$1009000,2005.8.1 ~ 2006.7.31
102﹒ 個別型,CMU94-018,侯庭鏞(Ho,Tin-Yun),吳世祿(Wu,Shih-Lu),本校(含附醫),抗肝癌中藥開發之研究 (II),$150000,2005.8.1 ~ 2006.7.31
103﹒ 個別型,NSC94-2320-B-039-012,黃麗嬌(Huang,Li-Jiau),侯庭鏞(Ho,Tin-Yun),科技部,Synthesis and anti-diarrheal activity of 2-(3(or 4)-hydroxy-4(or 3)-methoxybenzyl)oxy)benzoic acids and related compounds,$868000,2005.8.1 ~ 2006.7.31
104﹒ 個別型,NSC94-2320-B-039-026,謝慶良(Hsieh,Ching-Liang),唐娜櫻(Tang,Nou-Ing)、侯庭鏞(Ho,Tin-Yun),科技部,天麻和它的成分vanillyl alcohol保護人類神經母細胞瘤SH-SY5Y細胞抗H2O2誘發氧化傷害之研究,$1009000,2005.8.1 ~ 2006.7.31
105﹒ 個別型,DMR-95-027,陳清助(Ching-Chu Chen),侯庭鏞(Ho,Tin-Yun)、項千芸(Hsiang,Chien-Yun),本校(含附醫),腎素-血管加壓素系統抑制劑提升胰島素敏感度分子生物學作用機轉之探討,$120000,2005.8.1 ~ 2006.7.31
106﹒ 個別型,DMR-95-102,蘇珊玉(Shan-Yu Su),謝慶良(Ching-Liang Hsieh)、侯庭鏞(Tin-Yun Ho),附醫院內計畫,丹參及丹參酮對過氧化氫在人類神經母細胞瘤SH-SY5Y細胞造成氧化傷害之保護研究,$120000,2005.7.1 ~ 2006.6.30
107﹒ 個別型,NSC94-NU-7-039-001,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun),科技部,利用核醫分子影像作為新藥開發快速評估系統之建立及其應用 (II),$597400,2005.1.1 ~ 2005.12.31
108﹒ 個別型,94農科-4.1.3-牧-U1,項千芸(Hsiang,Chien-Yun),侯庭鏞(Ho,Tin-Yun)、吳世祿(Wu,Shih-Lu),農委會,鹿茸機能性成分之研究,$590000,2005.1.1 ~ 2005.12.31
109﹒ 個別型,NSC 93-2320-B-039-037,侯庭鏞(Ho,Tin-Yun),科技部,利用肝細胞癌化訊息傳導路徑為導引開發抗肝癌中藥之研究,$930000,2004.8.1 ~ 2005.7.31
110﹒ 個別型,NSC93-2320-B-039-029,黃麗嬌(Huang,Li-Jiau),侯庭鏞(Ho,Tin-Yun),科技部,合成芐氧基苯甲酸類緣化合物做為抗下痢藥,$830000,2004.8.1 ~ 2005.7.31
111﹒ 個別型,CMU93-CMS-03,侯庭鏞(Ho,Tin-Yun),吳世祿(Wu,Shih-Lu),本校(含附醫),抗肝癌中藥開發之研究 (I),$200000,2004.8.1 ~ 2005.7.31
112﹒ 個別型,NSC 93-2320-B-039-036,謝慶良(Hsieh,Ching-Liang),唐娜櫻(Tang,Nou-Ing)、陳玉芳(Chen,Yuh-Fung)、侯庭鏞(Ho,Tin-Yun),科技部,桂枝茯苓丸對缺血-再灌流急性腦梗塞大鼠的效用和機制,$930000,2004.8.1 ~ 2005.7.31
113﹒ 個別型,NSC 93-2815-C-039-010-B,侯庭鏞(Ho,Tin-Yun),陳妍寧,科技部,中藥抗發炎生物性反應圖譜及療效機轉之研究 (大專學生參與研究計畫),$39000,2004.7.1 ~ 2005.2.28
114﹒ 個別型,DMR-94-004,陳清助(Ching-Chu Chen),侯庭鏞(Ho,Tin-Yun)、張淳堆(Chwen-Tzuei Chang)、陳君萍,本校(含附醫),基於胰島素傳遞路徑開發改善胰島素抗性治療用中藥之研究,$200000,2004.7.1 ~ 2005.6.30
115﹒ 個別型,NSC 93-NU-7-039-001,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun),科技部,利用核醫分子影像作為新藥開發快速評估系統之建立及其應用,$569800,2004.1.1 ~ 2004.12.31
116﹒ 個別型,CMU92-CMS-04,侯庭鏞(Ho,Tin-Yun),吳世祿(Wu,Shih-Lu),本校(含附醫),肝細胞轉形分子機轉研究及其藥物之開發 (III),$220000,2003.8.1 ~ 2004.7.31
117﹒ 個別型,NSC92-2320-B-039-013,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun),科技部,利用Activator Protein 1為標的開發抗肝癌用藥之研究 (2/2),$971000,2003.8.1 ~ 2004.7.31
118﹒ 個別型,NSC92-2815-C-039-007-B,侯庭鏞(Ho,Tin-Yun),陳淑婷,科技部,中藥多重生物性反應圖譜之建立及其資料庫之分析 (大專學生參與專題計畫),$39000,2003.7.1 ~ 2004.2.28
119﹒ 整合型(召集人、總主持人),NSC 92-2751-B-039-005-Y,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun)、高尚德(Kao,Shung-Te),科技部,治療嚴重型急性呼吸道症候群中草藥開發-(子計畫四)抗SARS病毒中草藥之開發,$1889200,2003.7.1 ~ 2004.6.30
120﹒ 個別型,NSC 92-2751-B-039-001-Y,項千芸(Hsiang,Chien-Yun),侯庭鏞(Ho,Tin-Yun),科技部,生物可分解性口服SARS疫苗之研發,$1435500,2003.7.1 ~ 2004.6.30
121﹒ 個別型,DOH92-DC-1058,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun),衛福部,生物可分解性口服卡介苗之研發,$1450000,2003.1.1 ~ 2003.12.31
122﹒ 個別型,DOH92-TD-1007,項千芸(Hsiang,Chien-Yun),侯庭鏞(Ho,Tin-Yun)、吳世祿(Wu,Shih-Lu),衛福部,利用疾病相關轉錄因子活性建立保健食品多複方評估體系及有效成分快速搜尋系統,$750000,2002.8.1 ~ 2003.7.31
123﹒ 個別型,NSC91-2313-B-039-003,侯庭鏞(Ho,Tin-Yun),科技部,大腸桿菌忌熱性腸毒素B次單位蛋白質誘發細胞分化機制及其應用於下痢防治之研究(2/2),$874900,2002.8.1 ~ 2003.7.31
124﹒ 個別型,CMC91-CMS-04,侯庭鏞(Ho,Tin-Yun),吳世祿(Wu,Shih-Lu),本校(含附醫),肝細胞轉形分子機轉研究及其藥物之開發 (II),$180000,2002.8.1 ~ 2003.7.31
125﹒ 個別型,NSC91-2320-B-039-026,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun),科技部,利用Activator Protein 1為標的開發抗肝癌用藥之研究 (1/2),$851000,2002.8.1 ~ 2003.7.31
126﹒ 個別型,DOH91-DC-1041,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun),衛福部,生物可分解性口服卡介苗之研發,$1080000,2002.1.1 ~ 2002.12.31
127﹒ 個別型,NSC90-2313-B-039-002,侯庭鏞(Ho,Tin-Yun),科技部,大腸桿菌忌熱性腸毒素B次單位蛋白質誘發細胞分化機制及其應用於下痢防治之研究(1/2),$900000,2001.8.1 ~ 2002.7.31
128﹒ 個別型,CMC90-CMS-04,侯庭鏞(Ho,Tin-Yun),吳世祿(Wu,Shih-Lu),本校(含附醫),肝細胞轉形分子機轉研究及其藥物之開發,$200000,2001.8.1 ~ 2002.7.31
129﹒ 個別型,DOH90-DC-1007,侯庭鏞(Ho,Tin-Yun),項千芸(Hsiang,Chien-Yun),衛福部,生物可分解性口服卡介苗之研發,$1150000,2001.2.12 ~ 2001.12.31
130﹒ 個別型,CMC89-M-10,吳世祿(Wu,Shih-Lu),侯庭鏞(Ho,Tin-Yun),本校(含附醫),人類膠原蛋白I型基因啟動子轉錄調控之研究,$180000,2000.8.1 ~ 2001.7.31
131﹒ 個別型,NSC89-2313-B-039-004,侯庭鏞(Ho,Tin-Yun),科技部,微膠囊口服疫苗之研發Ⅱ,$800000,2000.8.1 ~ 2001.7.31
132﹒ 個別型,CMC89-CMS-04,侯庭鏞(Ho,Tin-Yun),吳世祿(Wu,Shih-Lu),本校(含附醫),四逆散對C型肝炎病毒體外複製之療效研究,$200000,2000.8.1 ~ 2001.7.31
133﹒ 個別型,NSC 89-2313-B-039-002,侯庭鏞(Ho,Tin-Yun),科技部,M細胞標的型微球體之開發,$799700,1999.8.1 ~ 2000.7.31
134﹒ 個別型,CMC88-CMS-04,侯庭鏞(Ho,Tin-Yun),本校(含附醫),人參皂苷誘發黏膜性免疫反應機轉之研究,$160000,1999.8.1 ~ 2000.7.31
135﹒ 個別型,NSC 89-2815-C-039-007-B,侯庭鏞(Ho,Tin-Yun),呂明怡,科技部,口服微膠囊疫苗製程之研究(大專學生參與專題研究計畫,$30000,1999.7.1 ~ 2000.2.28
136﹒ 個別型,CMC87-M-17,項千芸(Hsiang,Chien-Yun),侯庭鏞(Ho,Tin-Yun),本校(含附醫),大腸桿菌忌熱性腸毒素之研究,$200000,1998.8.1 ~ 1999.7.31
137﹒ 個別型,CMC87-M-07,吳世祿(Wu,Shih-Lu),侯庭鏞(Ho,Tin-Yun),本校(含附醫),肝硬化分子致病機轉之研究,$100000,1998.8.1 ~ 1999.7.31
138﹒ 個別型,CMC86-M-26,項千芸(Hsiang,Chien-Yun),侯庭鏞(Ho,Tin-Yun),本校(含附醫),泡疹病毒一型去氧核糖核酸分解酵素結構與功能相關性之研究,$193500,1997.8.1 ~ 1998.7.31
 
專利/Patent
(專利名稱,專利類別,專利國別,專利號碼,專利期間)
1﹒ 鳶尾黃酮苷及含有其的萃取物用於製備治療肺部炎症反應之藥物的用途,發明專利,台灣,發明I669122號,2019.8.21 ~ 2038.6.19
2﹒ 多胜肽用於製造治療或/及預防與靶點相關疾病之醫藥組合物之用途,發明專利,台灣,發明第I593703號,2017.8.1 ~ 2034.8.24
3﹒ 多胜肽、編碼該多胜肽之核酸分子、以及該多胜肽之應用,發明專利,台灣,I588153,2017.6.21 ~ 2032.5.17
4﹒ 多胜肽用於製造活體多效應之醫藥組合物之用途,發明專利,台灣,I580690,2017.5.1 ~ 2034.8.24
5﹒ ポリぺプチドを含有する生体內べ多くの効果を有する醫葯組成物及びその用途,發明專利,日本,特許第6116539號,2017.3.31 ~ 2034.12.3
6﹒ POLYPEPTIDES, NUCLEIC ACID MOLECULE ENCODING POLYPEPTIDES, AND USES OF POLYPEPTIDES,發明專利,歐盟,EP 2940035,2016.9.21 ~ 2032.8.9
7﹒ ポリペプチド、ポリペプチドをコードする核酸分子、及びポリペプチドを含む医薬組成物,發明專利,日本,特許第5947872號,2016.6.10 ~ 2032.9.10
8﹒ POLYPEPTIDES, NUCLEIC ACID MOLECULE ENCODING POLYPEPTIDES, AND USES OF POLYPEPTIDES,發明專利,歐盟,EP 2664622 B1,2015.10.7 ~ 2032.8.9
9﹒ A polypeptide from Mormodica charantia for use for the regulation of genes related to inflammation, lipid and glucose metabolism,發明專利,歐盟,EP2990050 A1,2015.7.1 ~ 2035.6.30
10﹒ POLYPEPTIDES, NUCLEIC ACID MOLECULE ENCODING POLYPEPTIDES, AND USES OF POLYPEPTIDES,發明專利,美國,US 9,029,326 B2,2015.5.12 ~ 2032.7.24
11﹒ ポリペプチド、ポリペプチドをコードする核酸分子、及びポリペプチドを含む医薬組成物,發明專利,日本,特許第5676538號,2015.1.9 ~ 2032.9.10
12﹒ Modified Sodium Iodide Symporter Proteins and Uses Thereof,發明專利,歐盟,EP 2412723 A1,2014.12.31 ~ 2030.11.9
13﹒ Modified Sodium Iodide Symporter Proteins and Uses Thereof,發明專利,美國,US 8,852,576 B2,2014.10.7 ~ 2031.9.30
14﹒ Blood Sugar-Modulating Polypeptides,發明專利,歐盟,EP2191837B1,2014.5.7 ~ 2029.3.4
15﹒ POLYPEPTIDES, NUCLEIC ACID MOLECULE ENCODING POLYPEPTIDES, AND USES OF POLYPEPTIDES,發明專利,美國,US 8,697,649 B2,2014.4.15 ~ 2032.7.24
16﹒ BLOOD SUGAR-MODULATING POLYPEPTIDES,發明專利,美國,US 8,476,229 B2,2013.7.2 ~ 2030.1.13
17﹒ 改変ヨウ化ナトリウム共輸送体タンパク質及びその使用,發明專利,日本,特許第5234846號,2013.4.5 ~ 2030.11.7
18﹒ 經修飾之鈉碘共同轉運蛋白質及其應用,發明專利,台灣,發明第I379900號,2012.12.21 ~ 2030.7.27
19﹒ 多胜肽、編碼該多胜肽之核酸分子、以及該多胜肽之應用,發明專利,中國大陸,ZL 201210164364.4,2012.12.14 ~ 2032.5.23
20﹒ 多勝肽、編碼該多勝肽之核酸分子、以及該多勝肽之應用,發明專利,香港,HK1189607,2012.5.24 ~ 2032.5.23
21﹒ 血糖值の上昇を抑制するための醫藥組成物及び血糖值の上昇を抑制するための藥の製造のためのポリペプチドの使用,發明專利,日本,特許第4772884號,2011.7.1 ~ 2031.6.30
22﹒ 具血糖調控功能之多胜肽,發明專利,台灣,發明第I 342781號,2011.6.1 ~ 2028.11.30
23﹒ 经修饰的钠碘共同转运蛋白质及其应用,發明專利,中國大陸,ZL2010 1 0245857.1,2010.8.5 ~ 2030.8.4
24﹒ 多胜肽、編碼該多胜肽之核酸分子、以及該多胜肽之應用,發明專利,日本,特許第5676538號, ~
 
獲獎/Award
(獲獎名稱,給獎單位,獲獎日期)
1﹒ 107年度科技部傑出研究獎,科技部,2018.12.31
2﹒ 「創新創業激勵計畫」,科技部,2018.11.26
3﹒ 2018未來科技展,科技部,2018.09.26
4﹒ 106年度大專學生研究計畫研究創作獎,科技部,2018.07.31
5﹒ 103年國家發明創作獎,經濟部,2014.11.13
6﹒ 科技部103年度傑出技術轉移貢獻獎,科技部,2014.11.25
 
技術轉移/Technology Transfer
(技術名稱,發明人,合約期間,專利名稱,授權單位,授權單位名稱)
1﹒ 「苦瓜多胜肽萃取液功效研究」在保健食品之開發,侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang),2014.3 ~ 2034.3,,本校(含附醫),綠茵生技股份有限公司
2﹒ 「具血糖調控功能之多胜肽」在苦瓜(Momordica charantia)血糖調控保健食品之開發,侯庭鏞(Tin-Yun Ho)、項千芸(Chien-Yun Hsiang),2013.8 ~ 2033.8,具血糖調控功能之多胜肽,本校(含附醫),綠茵國際行銷有限公司